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ABSTRACT OF THE DISSERTATION
THIN FILM BASED BIOSENSORS FOR POINT OF CARE DIAGNOSIS
OF CORTISOL
by
Syed Khalid Pasha
Florida International University, 2018
Miami, Florida
Professor Shekhar Bhansali, Major Professor
In this research, the design and development strategies for thin film-based
biosensors are explored to achieve rapid, sensitive, selective, and label-free detection
of cortisol in the physiological range [0.05µg/dL(saliva) to 25µg/dL(blood)]. Cortisol
is a steroid hormone which is related to the physiological stress. Increased cortisol
levels have been associated with stress-related diseases, including chronic fatigue
syndrome, irritable bowel syndrome and post-traumatic stress disorder. Therefore,
accurate measurement of cortisol in saliva, serum, plasma, urine, sweat, and hair, is
gaining increasing clinical significance to predict multiple physical and mental
diseases.
Thin film based electrochemical immunosensors were fabricated using a selfassembled monolayer (SAM) functionalized by specific antibodies to detect cortisol
in the presence of a redox probe. The fabricated electrochemical cortisol
immunosensors were able to detect cortisol in human saliva samples at 10 pM level
sensitivities. The results of the sensor were validated using the standard Enzyme
Linked Immuno Sorbent Assay (ELISA) technique. To improve the signal
amplification and label-free cortisol detection, copper nanoparticles were on the
screen-printed carbon electrodes (SPCE) for the fabrication of electrochemical
vii

cortisol immunosensor. This SPCE-based sensor showed a sensitivity of 4.21µA/M
and limit of detection 6.6nM.
However, both SAM and SPCE based immunosensors exhibited a
shortcoming of thermal stability due to the biological nature of antibodies at room
temperature. To overcome this challenge, an antibody-free sensing platform based on
molecular imprinted polymer (MIP) was developed. The design of this cortisol sensor
depends on the selection of an appropriate polymer-base, wherein the sensing is
dependent on the cortisol molecule’s adsorption on the polymer substrate. A polypyrrole, a conducting polymer, was selected to fabricate MIP using electrochemical
polymerization of pyrrole.

The MIP based sensor detected cortisol in the

physiological range at room temperature. The performance of this sensor was tested
on saliva samples and the results were validated by the conventional ELISA
technique. This MIP based cortisol sensor is cost-effective, easy to fabricate,
temperature stable, and reusable.
Aiming to perform cortisol sensing at point-of-care (POC), an Extended Gate
Field Effect Transistor (EGFET) was integrated with a developed MIP cortisol sensor.
The as developed MIP-EGFET sensor was used to detect the cortisol concentration in
the range of 10 pM to 100 nM. Some of the salient features of the developed sensor
are its ability to provide a direct readout and a simpler electronic system. These
attributes enable the POC device development of the reduced form factor.
A sensing strategy consisting of integrating MIP cortisol sensor with an
extended gate field effect transistor (EGFET) configuration was demonstrated to
perform cortisol sensing at point-of-care (POC). The MIP-EGFET configuration
protects the active device from the liquid environment and enables the relatively
simple, label-free, portable and direct measurement system for cortisol sensing.
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INTRODUCTION

1.1

Motivation
Everyday experiences, events and lifestyle have been known to cause

psychological stress, leading to adverse health outcomes. Although the human body
reacts to stress in different ways, a typical response is the release of hormones and
neurotransmitters. Prolonged exposure to stress causes the activation of signaling
pathways from the brain that leads to the release of cortisol from the adrenal cortex.
Various signaling pathways are affected by psychological stress. Cortisol “a steroid
hormone” has been widely used for estimation of stress and exposure to chemicals.
Cortisol secretion levels have been correlated to stress levels in patients suffering
from stress disorders such as Post Traumatic Stress Disorder (PTSD), Cushing's
syndrome, insomnia and burnout. Cortisol has also been

used as a marker for

determining the effect of exposure to external chemicals, such as the effects of
organophosphates on the central nervous system, which alter the endocrine system,
leading to an imbalance in cortisol secretion. The secretion of cortisol in individuals
depends on the circadian rhythm and the environment. Hence its variations during the
day at Point of Care (POC) are essential for personalized diagnosis and treatment. The
detection of cortisol is based on immunoassays like chromatography, Enzyme Linked
Immuno Sorbent Assay (ELISA) and Radioactive Immune Assay (RIA). These
systems are bulky, expensive, require labels to operate and do not provide quick
results. In contrast, Electrochemical (EC)/electrical (FET, chemiresistive, etc.) sensors
demonstrate better sensing performance, can be made label-free, micro-fabricated, can
provide faster results and are suitable for miniaturization. Due to their advantages
1

over optical, spectroscopic and mechanical sensors, electrochemical/electrical sensors
were extensively explored for application towards POC systems [2-8].
Electrochemical cortisol sensing platforms reported in this research have the
potential to be integrated into a POC system for online continuous monitoring of
cortisol as a function of one’s environment.
POC sensing systems consist of biosensors and bio-analytical devices. These
systems are crucial for detection of a targeted analyte outside controlled environments
of diagnostic labs and hospitals. These devices have a major impact on the
applications of personal care, health, food, and environmental monitoring. An ideal
POC biosensor device allows real-time, rapid, label-free, and multiplexed detection
with high selectivity and sensitivity [8].
However, there are several challenges in implementing POC sensors. The
requirement of redox media for electrochemical sensing adds to design complication
for POC devices. The lack of robustness due to the temperature sensitivity of
detection molecules (antibodies, enzymes) pose logistical challenges involving
increased costs associated with storage at temperatures below zero. The complexity of
the electronic system associated with these devices also prevents them from being
miniaturized for POC application. To address the above challenges in thin film-based
detection of cortisol, this research was performed with the following specific aims in
mind.

2

1.2

Specific Aims

1.2.1

Specific Aim 1: Electrochemical immunosensors on a gold thin film based

Inter Digitated Electrodes (IDEs) and their validation against ELISA using Human
saliva samples
The first activity to be undertaken in this research was the fabrication of
electrochemical immunosensors on Au thin film-based IDEs. The Au surface was
functionalized using SAM of DTSP molecules. Cortisol specific Antibodies were then
immobilized on this functionalized surface, and non-binding sites blocked using
Ethanolamine (EA). These sensors were calibrated and used for detection of cortisol
in human saliva samples. The same samples were tested for cortisol using the standard
ELISA process. The results obtained using both procedures were compared to validate
the electrochemical immunosensing protocol.

1.2.2

Specific Aim 2: Nano enabled signal amplification in SAM based

electrochemical cortisol Immunosensors.
Electrochemical sensors have a limitation where a redox label is required for
sensing. In order to address the issue of label-free sensing, SPCE were modified
electrochemically with Cu/CuO nanoparticles. The nano-modified SPCE were
characterized by SEM, XRD and by CV. These nano-enabled SPCE were then used to
fabricate SAM based Immunosensors using cortisol specific antibodies. The nanoenabled immunosensors were then used to detect the different concentration of
cortisol in a test sample.

3

1.2.3

Specific Aim 3: Biomimetic sensors for label-free, temperature stable and

repeatable measurements of cortisol
MIPs were explored to address the challenges associated with previously
fabricated immunosensors (temperature stability, label-free sensing, repeatability and
direct output of sensing data). MIP thin film were formed on an SPCE surface using
electro-polymerization of pyrrole. The substrates were then optimized and
characterized.
The MIP modified electrodes were then be used for electrochemical sensing
and demonstrate cortisol detection. The fabricated sensors overcame some of the
challenges associated with the ECIS described above. These sensors do not use
expensive antibodies. Hence, the fabrication costs associated with them are meager.
Repeatable sensing of cortisol was also demonstrated with the same MIP based
electrode to allow for potential wearable applications.

1.2.4

Specific Aim 4: Integration of EGFET with MIP based substrate for

Sensing Cortisol- A direct approach.
The electrochemical sensors have limitations with regards to label-free sensing
and providing a direct readout of the sensing results. To address these limitations, a
much simpler approach to sensing was explored. The MIP based electrodes were
integrated with a FET to give an EGFET configuration. The EGFET-MIP sensors thus
fabricated allowed label-free detection of cortisol and provided direct readout by
modulating drain current as a function of cortisol concentration. This approach also
allows for less complexity regarding auxiliary instrumentation which is required for
miniaturized devices.
4

1.3

Dissertation Organization
In this Dissertation, we report the development of biosensors for the detection

of cortisol which has potential application towards the point of care use. In Chapter 1,
the motivation for this research and specific aims are discussed. In Chapter 2, cortisol
and its importance in the body are presented. Also discussed are the state of the art
techniques available for the detection of cortisol. In Chapter 3, the fabrication and
characterization of electrochemical immunosensors based on the gold thin film is
presented. The results related to the validation of these sensors against standard
ELISA technique were also discussed in this chapter. Chapter 4 reports the
development of a nano-modified electrochemical immunosensor for achieving labelfree sensing of cortisol. Chapter 5 and 6 present the design, fabrication, validation,
and application of Molecular Imprinted Polymer based sensors in electrochemical and
electronic (EGFET) configuration. These chapters address the issues associated with
the devices reported in the previous chapters. The summary of the research
undertaken, and future prospects are discussed in Chapter 7.

5

BACKGROUND AND LITERATURE REVIEW

2.1

Biosensing
Medicine and healthcare have been evolving ever since the dawn of humanity.

They are based on a system of observation and treatment of symptoms. The only tools
available for diagnosis in early times were the sense of smell, sight, touch, and
hearing. Patients were treated based on how their symptoms responded to a medicine.
It was the case until the late nineteenth century. The evolution of scientific tools such
as microscopes, stethoscopes, etc. helped in the diagnosis of diseases. During the 20th
century, the development of chemical analysis tools such as gas chromatography [9],
paper chromatography, mass spectroscopy, etc. enabled researchers to estimate the
amount of targeted chemicals in a healthy and diseased specimen. The development
of chemical analysis techniques allowed health care providers to form their diagnosis
better and treat the patients accordingly. The detection of biochemical markers and
their association with certain diseases paved the way for modern medicine and health
care. The improved accuracy of the diagnosis saved countless lives. However, the
bulky nature of the detecting equipment, the sample collections techniques, elaborate
sample preparation and longer times to detection have made these diagnostic
techniques expensive and limited them to labs [10-17].
Efforts are being made to make the detection of biomolecules fast, easy and
cheap. One of the pioneering works in the development of such a system was by
Leland C Clark in 1965[18]. He pioneered the development of an oxygen sensor. This
sensor was later modified to detect glucose molecules in a drop of blood. This

6

technology resulted in a portable glucose meter still being used by millions of
diabetics across the world to monitor their blood glucose levels every day.
However, there are very few biosensing systems available in the markets that
come close to achieving a cheap, portable and easy to use system. The conventional
techniques of diagnosis involve sample collection, shipping to the diagnostic lab, and
involve elaborate sample preparation techniques before analysis. Despite being
expensive, cumbersome and time-consuming, these techniques are still a viable option
for quantification of biomolecules.
The proposed market share of personalized healthcare monitoring systems is
estimated globally to be more than $ 20 billion [19]. In order to bridge the high supply
gap, researchers focused on the development of POC sensors. Several modes of
biosensing were explored (optical electrochemical, electrical, etc.) to achieve easy,
miniaturized and cost-effective devices.
Today most of the biosensors used are affinity-based. That means they are
based on the interaction between molecules that are complementary to each other.
Some of these complementary interactions are antibody-antigen coupling, aptamerprotein, DNA hybridization, etc.
According to the World health organization, world over, chronic diseases are a
leading cause of death and disability. Diseases such as cardiovascular, obstructive
cardiopulmonary, diabetes and cancer, etc. are significant concerns that adversely
affect the lives of millions across the globe [20]. These diseases are linked by
common and preventable lifestyle choice risk factors such as unhealthy diet, physical
inactivity, chronic stress, etc. Among these factors, chronic stress affects the
functioning of the body and inhibits normal functioning of the immune system. The
7

estimation of Stress is, therefore, a necessary tool that can help provide proper
diagnostics and healthcare to patients. This research will focus on the detection of
cortisol as the primary biomarker for detection of stress.

2.2

Why Cortisol?
Cortisol is a steroid hormone produced in the body as a response to stressor

events (physical and psychological). As a steroid hormone, cortisol is produced as
part of the body’s stress response. It is secreted by the hypothalamic-pituitary-adrenal
(HPA) system. Normal levels of cortisol secretion follow a circadian rhythm and
fluctuate significantly through a 24-hour cycle with cortisol levels highest during
daybreak (30 minutes after awakening) and progressively lower as the day progresses
to a minimum during night sleep [21, 22] (Figure 1).

Figure 1: Chemical structure of cortisol and typical diurnal variation of cortisol levels over a
24-hour cycle [21,22].
Apart from the day-night cycle, several controllable factors can affect cortisol
levels such as eating patterns and physical activity. While the abnormal increase in
cortisol levels inhibits inflammation, depresses the immune system, increases fatty
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and amino acid levels in blood [23], it is essential in maintaining a healthy metabolic
rate and help in the daily functioning of many bodily functions [24-26]. Excess
cortisol levels in the body have been shown to be associated with the development of
Cushing’s disease with the symptoms of obesity, fatigue and bone fragility [23]. On
the other hand, a decrease in cortisol levels leads to Addison’s disease which
manifests in the form of weight loss, fatigue, darkening of skin folds and scars [27].
The most dominant effect on cortisol variation comes from psychological/emotional
stress, which is why cortisol is popularly called the “Stress-hormone” [28].
Increasing level of psychological stress due to competitive living style is
becoming a serious concern in the everyday schedule. Also, life-threatening diseases
like heart attack, depression, and brain pain are the health challenges faced by most
developed countries [29]. The accurate and precise detection of psychological stress is
thus gaining attention for personalized health monitoring and diagnostics. The stress
cycles (Figure 2) in human find its ways into the nervous system and upsets the
chemistry of the entire body [30]. Cortisol abnormalities are often a good indicator of
chronic conditions such as Addison’s disease, Cushing’s syndrome, and adrenal
insufficiencies [23-26, 29]. Hence, real-time and continuous monitoring of cortisol
levels is required to obtain valuable information that could assist doctors in better
diagnosis and treatment of cortisol related conditions. In clinical practice, total
cortisol, which is the sum of free and protein-bound fractions, is measured. However,
free cortisol is the biologically active fraction [31] which is responsible for all cortisol
related activities in the body. Hence, to diagnose and properly treat cortisol-related
conditions, regular estimation of free cortisol is required. The state-of-the-art in
cortisol detection is mostly limited to laboratory-based techniques such as
chromatography [32-34], RIA [35], ECLIA [16, 36-39], ELISA [12, 40-42], SPR [439

45], QCM [46] etc. Detection of 24-hour cortisol levels is currently a cumbersome
process, which either involves admitting the patient for the time of the study [47] or
the patient depositing samples (blood, saliva, sweat or urine) into vials at specified
intervals during the 24-hour period and shipping of them to a diagnostic laboratory
[48]. The typical turnaround time is 3 to 8 days and is still not a true representation of
cortisol levels in stressful environments. At best they provide a momentary data that is
difficult to relate to the stressor events at the patient end. There is currently a need to
investigate cortisol sensing platforms that can be deployed at point-of-care (POC).

Figure 2: Stress cycle and its effect on human nervous system
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2.2.1

Secretion of Cortisol.
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Figure 3: Cortisol secretion regulated by the HPA axis and various bio-fluids
used for cortisol estimation
Cortisol is secreted from the adrenal glands located above the kidneys.
Cortisol is the product of the Hypothalamic-Pituitary-Adrenal (HPA) axis, which is
the main component of the human body’s adaptive system to maintain regulated
physiological processes under changing environmental factors. The HPA axis is a
complex signaling system between the hypothalamus in the brain, the pituitary glands
and the adrenal glands [24]. A typical response to an environmental trigger is initiated
by the hypothalamus that releases a hormone called the CRH (Corticotrophin
Releasing Hormone) that travels to the pituitary glands. Specialized cells that work
synergistically with the pituitary glands release ACTH (Adrenocorticotrophic
Hormone) into the bloodstream that travels to the adrenal cortex. The adrenal cortex
responds by increasing the production of cortisol. Since the adrenal glands have no
visible innervation, it can be inferred that ACTH is the sole stimulant for initiating
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cortisol production. The adrenal glands do not store cortisol, but they aid in the
production of cortisol. Cholesterol undergoes multiple catalyzed oxidation reactions
to result in the formation of cortisol. This entire process takes place in a time space of
a few minutes. The HPA axis is a negative feedback system, where Cortisol plays a
critical rule in the homeostasis of the HPA axis (Figure 3). Moderate homeostatic
alterations in the HPA axis is beneficial for the physiological and psychological
development of the human body, sustained and prolonged exposure to environmental
triggers such as stress leads to abnormal levels of cortisol in the circulatory system
[24]. Secreted cortisol finds its way into the circulatory system and can be found in
detectable quantities in several biofluids. In this section, an assessment of the
advantages and disadvantages of using various biofluids such as urine, blood, sweat,
interstitial fluid (ISF) and saliva for the detection of cortisol is presented.
2.2.1.1 Urine
Cortisol level in urine is measured over a 24-hour period and is referred to as
the 24-hour urinary free cortisol (UFC) test. Only free cortisol, which is the active
form of cortisol in the human body, is found in urine and is hence a relevant biofluid
for the detection of cortisol. The excretion of hormones, salts and other waste
chemicals through urine is a well-characterized process with good knowledge about
the concentration of these waste substances under normal function. Observation of
extreme variation in concentrations of hormones such as cortisol can be used to
diagnose abnormalities in the adrenal function. Measurement of cortisol in urine
typically requires the collection of all the urine generated over a 24-hour period. The
normal range for cortisol in urine is 10 to 100 μg/24hrs [49]. A review of the reported
literature for urinary cortisol assays has been presented by Brossaud et. Al. [49]
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While the 24-hour urinary free cortisol test provides a means for a noninvasive, painless method of obtaining body fluid for cortisol measurement, it also
poses several drawbacks with respect to convenience and reliability. Since the
collection of the urine is spanned over a 24-hour period, sample collection becomes
an inconvenient process where the patient needs to carry the special urine collection
container all day long or must remain confined to a location for the 24-hour period.
The container also needs to be stored under refrigeration from the time of collection
until it is delivered to a diagnostic lab for testing. Also, several factors such as
pregnancy and medication such as diuretics can alter the concentration of cortisol in
urine making it a less reliable biofluid for cortisol detection. These several additional
factors have severely limited the use of urine to cases where patients are admitted to
the hospital for long-term treatments. The requirement of 24-hour sample collection
renders urine unfit for real-time detection.
2.2.1.2 Interstitial Fluid (ISF)
ISF is an extracellular fluid that surrounds the cells in the human body. In
composition, it is similar to blood plasma. Metabolites and proteins move into ISF as
they move from capillaries to cells. In general, small to moderate sized molecules,
including glucose, ethanol, and cortisol are found in ISF in similar proportion as in
blood. Thus, periodic calibration using blood sampling is not required to obtain the
concentration of these metabolites from ISF. ISF is present just below the skin, but the
low permeability of the epidermal keratinized layer (the stratum corneum) blocks the
permeation of the fluid through the skin. However, obtaining ISF for detection of a
target biomarker could require an invasive approach as it is not readily accessible.
Several approaches have been reported in the literature to obtain ISF in a minimally
invasive, painless process. Venugopal et al. [50] have reported the construction of an
13

ISF harvesting system that utilizes a low-energy laser to create micropores in the
stratum

corneum

(the

uppermost

layer

of

dead

cells).

Figure 4: Left to right- Cross-section of micropore generated through laser ablation;
Four pores relative to the size of a penny; Handheld laser source used to create micropores [51].
The diameter of the micropores is approximately equal to that of a human hair.
The micropores only penetrate the stratum corneum and, hence, this procedure is
virtually painless. ISF is drawn through these micropores continuously by application
of a small amount of vacuum pressure (Figure 4). Harvesting of ISF using this set-up
is reported at a rate of 10µl/hr. Coupled with an electrochemical detection system,
Venugopal et al. [51] have reported the detection of cortisol using the same microporation set-up. Cortisol levels in ISF were found to be 3 – 4 times larger than that in
saliva, which makes ISF an attractive biofluid for detection of cortisol. While this setup may provide a means to access ISF for cortisol detection, the low harvesting rate
(10µl/hr) would limit its applicability for obtaining instantaneous cortisol values in a
point of care setting. Micromachined microneedles for transdermal application are
another option to harvest ISF [52, 53]. Microneedles have been used extensively for
transdermal drug delivery [53, 54]. Mukerjee et al., have reported the design,
fabrication, and testing of a hollow microneedle array containing fluidic
microchannels for the transdermal extraction of ISF from human skin [55]. Wang et
al. [56] have also reported the fabrication of glass microneedles for ISF extraction for
glucose monitoring. These approaches show promise for creating painless, minimally
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invasive methods for extraction of ISF. Microneedles based transdermal ISF
extraction may find suitable application in wearable biosensing system, where there is
a critical need to continuously sample body fluids such as ISF at a low sampling rate.
However,

concerns

regarding

biocompatibility

and

biodegradation

of

the

microneedles, protection from infection due to the usage of needles and other sterility
issues will need to be carefully addressed for successful implementation.
2.2.1.3 Sweat
Sweat analysis is a well-established method for certain diagnosis of conditions
such as cystic fibrosis and drug abuse. Sweat patches could be used as effective noninvasive tools to collect biofluids [57]. Cortisol in sweat has been measured by
Russell et al., [58] with cortisol concentrations ranging from 141.7 ng/mL (daytime)
to 8.16 ng/mL. It is hypothesized that there exists a strong correlation between
cortisol levels in sweat and hair due the path that cortisol traverses from serum,
sebum, and sweat to the hair. However, very little is known about cortisol in sweat,
and several inherent drawbacks exist in obtaining reliable samples to measure cortisol
in sweat accurately. Perspiration is dependent on several factors such as weather
conditions (humidity, temperature), geographic conditions, physical activity levels,
ambient temperature or conditioned temperature and genetic make of the patient.
Development of microfluidic sweat collection cloth has been proposed as further
advancement in sweat-based cortisol detection where sweat will be collected using the
cloth patches and analyzed using an integrated device [59].
2.2.1.4 Blood
More than 90% of cortisol in blood is in an inactive state being bound to
corticosteroid binding globulin (CBG) and serum albumin. Only 10% of total cortisol
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is in a biologically active state to participate in cortisol-initiated processes. Typically
assays for measuring cortisol in blood involves measuring the total cortisol (bound +
free) and then the active fraction, called the Cortisol Free Index (CFI) is deduced
using the Coolen’s equation [60]. Blood sampling for cortisol detection has been the
oldest form of biofluid sampling. The nominal value for cortisol in blood varies from
25µg/dL (9AM) to 2µg/dL (midnight). Blood, however, is afflicted by many
drawbacks, which has made it a last choice sampling fluid. Sampling blood required
attention from medical staff and specialized, sterile equipment with an ever-existing
concern for infections. While cortisol is an unstable molecule at room temperature, its
presence in plasma requires special handling and storage condition as it is considered
a biohazard. Since sampling blood requires puncture of veins, a painful procedure, the
stress experienced by patients prior to and during sampling may elevate cortisol levels
[26]. Although the typical response time for cortisol spiking is 10 to 15 minutes in
humans, prior knowledge of venipuncture can initiate the stress response induced
cortisol spiking. Also, the costs associated with staff, equipment, handling, and
storage makes blood-based assay a shunned option.
2.2.1.5 Saliva
Over the last few years, saliva has gained considerable attention as a biofluid
for analysis and detection of cortisol concentrations. This has come about mainly due
to inherent advantages associated with saliva. First and foremost, a well-documented
and studied the strong correlation between salivary and blood cortisol levels [61, 62].
Also, of high importance is the fact that cortisol in saliva exists entirely in the free
state unlike in blood (90% bound), resulting in detection of the relevant (biologically
active) form of cortisol. This is mainly due to the filtering of the CBG and Albuminbound cortisol during the capillary exchange and other intracellular mechanisms at the
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salivary ducts. Harvesting sample for analysis is almost entirely non-invasive with
little or no discomfort to the specimen providing the sample [63]. The last few years
have seen the establishment of standardized procedures for the collection of saliva,
which has led to lesser variability in analyzed results. The samples can be harvested
with minimum efforts that have facilitated patients to collect their own samples at
home. The advantages associated with salivary techniques have led to saliva being on
the verge of becoming the preferred source of body fluid for detection of cortisol.
Also, the ease of sample collection, handling, and storage has heightened its prospects
for applying in point of care sensors for real-time and continuous detection of cortisol.
However, there are certain aspects that may adversely affect the prospects of
saliva-based cortisol detection. Since only the active component of cortisol (free
cortisol) is present in saliva, the concentration of cortisol is much lower than that of
blood. Moreover, the room temperature instability of salivary cortisol possesses the
problem of storage during on-site detection, the nominal values for cortisol in saliva
during the diurnal cycle varies from 0.5µg/dL to 0.05 µg/dL, which requires high
sensitivity assays with low detection limits for efficient detection of cortisol
concentration in saliva. Strict compliance with the standard operating procedure for
saliva collection can lead to erroneous results. Sometimes, the presence of blood due
to oral lesions may lead to elevated levels of cortisol and cause erroneous results.
Salivary cortisol assays have been reported in the literature extensively for
characterizing the circadian rhythm [64], Cushing’s syndrome [65], Addison’s disease
[66], adrenal abnormalities [67] and stress-related disorders [68].
The detailed explanation of cortisol detection in various bio-fluids using
different techniques with recent advancements with further research & development at
POC detection is explained in the next section.
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2.2.2

Different methods of Cortisol detection
Among the label-free technologies for biomarkers detection, salivary

electrochemical immunosensing has emerged as the most promising technologies for
POC cortisol detection systems. Electrochemical immunosensing is based on the
principle of measuring the changes in electrical properties of a conductive material
due to the adsorption of an analyte on the surface functionalized with antibodies [8,
69, 70]. The electrical change is attributed to the change in the concentration of the
electroactive redox species at the electrode. The mature processing capability of the
micro-fabrication industry has allowed the building of microelectrodes that are highly
sensitive and provide low detection limits. The simplicity of electronic circuitry for
electrochemical detection and cheap volume manufacturing has driven efforts to bring
electrochemical immunosensing up to speed with other immunosensing techniques
[71, 72].
In recent years there have been many reports of electrochemical sensing of
cortisol using electrochemical impedance spectroscopy [73] and cyclic voltammetry
(CV) [74] based electrochemical cortisol immunosensor. Immunosensor has also been
integrated with microfluidic systems for POC sensing [74, 75]. These reports
demonstrate a workable cortisol sensing system using commercial cortisol sample.
However, their application in the field is still lacking.

2.2.3

Optical/ radiological immunosensing
Amongst one of the first biosensing techniques, RIA holds a special place. It is

an in vitro assay measuring accurately, the amount of antigen presents in a sample.
The technique was introduced by Berson and Yalow in the ’60s [76]. They performed
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an assay to determine the concentration of insulin in plasma. The technique relies on
the specificity of antibodies to antigens. A chemical label is tagged to either an
antigen whose concentration needs to be detected or to the antibodies. The label reacts
as a part of the assay and produces a signal that can be measured in the solution. In
the case of RIA, such a label is a radioactive compound, the activity of which is
measured using a radiation counter. Other labels cause a change in color/ fluorescence
of the solution. This change is dependent on the concentration of the target to be
detected. These techniques are standardized and available commercially [16, 32, 33,
35-39]. They show good sensitivity in the order of a few picograms in a solution.
However, the accompanying instrumentation, elaborate sample procedure and
extensive labor involved in processing the samples make it a costly affair. Among all
the available labeled immunoassays, ELISA has been found to be the most sensitive
and versatile and today, is considered the gold standard in protein concentration
determination. ELISA is typically performed in a sandwich format, where an
enzymatic substrate is added to the secondary antibody to amplify the colorimetric or
fluorescent signal, thereby providing high sensitivity. Detection of cortisol using
ELISA is used widely [12, 41] and often has been the technique used to validate
results obtained from newer techniques being developed for cortisol detection [42].
Manenschijn et al., collected hair samples of 195 healthy individuals, 9
hypercortisolemic and one hypocortisolemic patient to estimate cortisol using a
salivary ELISA kit [40]. A positive correlation between hair cortisol and both waist
circumference (r = 0.392, p = 0.007) and waist-to-hip ratio (WHR) (r = 0.425, p =
0.003) was found and no correlations were found between hair cortisol levels and
blood pressure or age. While ELISA is the most widely used technique in research
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labs and industry, the method is limited by the need for large sample and reagent
volumes and complexity arising from multiple assay steps and large incubation times.

2.3

Electrochemical Immunosensors
Among the immunosensors, electrochemical immunosensors have been

explored for detection of cortisol in recent times. In electrochemistry, the chemical
changes can be related to the flow of electrons that give rise to oxidative or reductive
species. Electrochemical immunosensing is based on the principle of measuring the
changes in electrical properties of a conductive material due to the adsorption of an
analyte on the surface functionalized with antibodies [8, 69, 77].
The change in the electrical charge due to the change in concentration of
electro-active species at the electrode surface caused by the change of analyte
concentration is utilized for sensing. The processing capabilities of the
microelectronics industry have allowed fabrication of microelectrodes that provide
high sensitivity and low detection limits.
The use of electrochemical immunosensing has advantages over conventional
techniques. Fast response times (from sampling to result), ease of fabrication, bulk
manufacture ability, small sample volumes and miniaturized supporting electronics
makes them a suitable candidate for Point of care detection of cortisol. [8, 78]. Sun et
al., reported cortisol antibodies immobilized on micro-fabricated Au electrodes for
immune-electrochemical sensing using alkaline phosphatase (AP) enzyme for
determination of salivary cortisol [79]. During the biochemical reaction, p-nitrophenol
(pNP) generated via reaction between AP enzyme attached to the cortisol and
antibodies in p-nitrophenyl phosphate (pNPP) solution pNP was detected using CV at
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room temperature (Fig. 11). The fabricated immunosensor exhibited a detection limit
of cortisol in saliva as 0.27 ng/mL with an incubation time of 10 min.
Dithiobis (succinimidyl propionate) (DTSP) self-assembled monolayer (SAM)
modified interdigitated µ-electrodes (IDEs) were used for the immobilization of
Cortisol specific monoclonal antibody

(C-Mab) to detect cortisol using

electrochemical impedance (EIS) technique [80]. EIS immunosensor exhibited the
sensitivity of 2.855 kΩ/(pg/mL) and found to detect cortisol in the range of 0.36
pg/mL to 0.36 ng/mL nM in saliva. This group has further used the same
immunosensing strategy to detect cortisol in ISF in vitro [73, 81]. EA/CMab/DTSP/Au based biosensor can accurately detect cortisol in the range of 0.36
pg/mL to 0.36 ng/mL with the detection limit of 0.36 pg/mL. The performance of this
EIS based immunosensor was validated using ELISA. Authors purposed the
feasibility of using impedance-based biosensor as a disposable cortisol detector,
capable of working with complex bodily fluids (e.g., saliva and ISF) at point-of-care.

2.3.1

Cyclic Voltammetry
One of the most common electrochemical tools that are used for such

biosensing is CV [82]. It is a powerful technique that is used for analysis of oxidized
and reduced species. Using an electrochemical cell that typically comprises of
working, reference and counter electrode, antibodies and antigen binding is estimated
as a function of the redox current in the presence of a conducting media. For taking a
CV scan, a varying potential is applied to a 3-electrode system and the response
current measured. The positive peak in the voltammogram is known as the oxidation
peak and the negative peak is the reduction peak. The oxidation and reduction
responses can be explained using the Nernst equations. This equation relates the
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potential of an electrochemical cell (E) to the standard potential of a species (E0) and
the relative activities16 of the oxidized (Ox) and reduced (Red) analyte in the system
at equilibrium.

𝐸 = 𝐸0 +

𝑅𝑇 (𝑂𝑥)
ln
𝑛𝐹 (𝑅𝑒𝑑)

Equation 1

Where R is the universal gas constant, F is the Faraday’s constant, n is the
number of electrons and T is the temperature.
While looking at a one-electron reduction system, the Nernst equation can be
utilized in such a way as to replace the activities with their concentrations (more
easily determined by experimentation). The standard potential can be substituted with
formal potential E0’ and n is equal to one.

𝐸 = 𝐸 0′ + 2.3026

𝑅𝑇
[𝐹𝑐+]
𝑙𝑜𝑔10
𝐹
[𝐹𝑐]

Equation 2

This equation is an excellent model to predict the change in the system with
respect to change in the concentration of the chemical species or the electrode
potential. Most of the CV system utilizes a working electrode, a reference electrode
and a counter electrode in an electrochemical cell. One can link the change in
oxidation and reduction potentials to the electron transfer at the surface of the
working electrode (Figure 5). This phenomenon can be utilized for biosensing where
the surface of the electrode is functionalized with detecting molecules not limited to
antibody-enzyme, and aptamers.
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The interactions between the antigen and the detecting moieties result in a
change in the redox current [82]. We explored interdigitated microelectrodes of gold
as a substrate for a CV based immunosensor. The developed sensor was used to detect
the various concentrations of cortisol. The above sensor was further used to detect
cortisol in human saliva samples and was benchmarked against optical
immunosensing technique (ELISA) [83].

Figure 5: Schematic of strategies used for electrochemical immunosensing
2.4

Limitations of Electrochemical Immunosensors
Electrochemical

immunosensors

utilize

biomolecules

(antibodies

and

enzymes) for the detection of analytes. However, this causes the sensor to be unstable
at room temperature and a constant need for storing available sensors in the
refrigerator. This prevents Point of Care application of electrochemical sensors.
Though label-free sensing techniques have been devised, they have not seen
production yet. Another important factor while considering electrochemical sensing is
the complexity of accompanying instrumentation. There have been efforts for making
cheap and portable electronics that can fully realize the potential of electrochemical
sensors for point of care.
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2.5

Label-free Detection
To overcome the tedious processes, cost and shortcomings of the current

detection methods, the focus has shifted to developing label-free immunosensing
techniques with high sensitivity, lower detection limits and broader detection range
[84]. One such technique that demonstrates label-free detection is based on Surface
Plasma Resonance (SPR) [44].
SPR works on the principle of oscillation of valence electrons in a conducting
substrate irradiated with light. SPR is highly sensitive to adsorption of molecules onto
the substrate, where the resonance curves shift to higher wavelengths with adsorption
of molecules onto the surface. SPR has shown promise as a method to quantitatively
measure the capture of the analyte on substrates coated with antibodies. The
associated detection optics and electronic for SPR measurement can be reduced to
miniaturized form factors and has hence attracted efforts to create point-of-care
immunosensors [43]. More recently, detection of cortisol in saliva [45] and other
biofluids using SPR has been reported in the literature. On the same lines as SPR,
another technique gaining ground for immune-sensing is based on the resonance
property of quartz crystal microbalance (QCM) [46]. Cortisol antibody was layered
onto the Au gold electrodes of a 10 MHz piezoelectric crystal to fabricate a
piezoelectric crystal immunosensor for the detection of cortisol [85]. Piezoelectric
crystal was pre-cleaned, protein-A and immunosensors detected cortisol at
concentration range 3.628 μg/mL. The proposed sensor includes elements of
simplicity, short analysis time, cost-effectiveness and selectivity. However, there is a
scope for improvement with respect to its detection limit.
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Label-free sensing has also been demonstrated using Nanomaterials while
doing CV measurements. Kaushik et all used Nanoparticles of Ag/AgOx core-shell
nanoparticles in a polymer matrix of Polyaniline to make an immunosensor for
cortisol. This work tries to explore the fabrication and utilization of Copper oxide
nanoparticles on a screen-printed carbon electrode for sensing purpose. The modified
SPCE was used for making a cortisol immunosensor to demonstrate Label-free
sensing. The fabricated sensor showed a sensitivity of 421 uA/M and had a limit of
detection as 6.6 nM cortisol.

2.6

Reusable Sensors- MIPs
In nature, antibodies have receptor sites that can bind to specific antigens and

function as an ultimate sensor. However, replication of such a sensing system by
artificial means has been quite challenging. The use of antibodies in biosensors has
been indispensable due to their sensitive and selective properties. However, their
production requires significant effort and cost. This system can be mimicked using
molecularly imprinted polymers at much less cost and effort. MIP are synthetic
polymers having highly specific recognition sites selective towards the target analyte.
The MIP-based biomimetic sensors have a considerable impact owing to their
potential application. They have advantages such as low cost, easy storage, and
applicability in harsh conditions. They also have long lifetimes as compared to
enzymes, antibodies, and proteins which require temperature and pH-controlled
environments for storage. Another attractive feature of MIP based biosensor is its
reversible binding with the target analyte which makes it highly reusable where
frequent/continuous monitoring is required. MIPs can be described as analogs to the
antibody-antigen mechanism. Their operation can be best described as a lock and key
25

mechanism that allows them to bind to target molecules selectively. The schematic
below (Figure 6) shows the fabrication scheme of a cortisol specific MIP sensor.
Several

production

methods

such

as

bulk

polymerization,

precipitation

polymerization, and emulsion have been demonstrated for the fabrication of MIPs.
However, controlled production and transfer of MIP to a transducer surface have been
challenging. This research will explore an electrochemical technique for the
manufacture of MIP. Electrochemical MIP fabrication enables control over thickness,
morphology, and reproducibility.

Figure 6: Schematic for fabrication of cortisol MIP biosensor on
SPCE surface.

2.7

The Field Effect Transistor

The FET was first proposed in the 1930s by Lilienfield [86] and developed for
practical use in 1960 by Kahng and Atalla [87]. The rapid growth and expansion of
the modern semiconductor industry can be attributed to the development of metaloxide-semiconductor-field-effect transistor (MOSFET) or the FET as it is known in
short. The FET has been an essential device for VLSI circuits and has been used in
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logic/ semiconductor memory devices as well. This has primarily been enabled due to
the miniaturization, cost reduction, and longer lifetimes offered by switching to ICs as
compared to Vacuum tubes. The integration of millions of complex active and passive
devices on a single silicon wafer has enabled a new and wide array of applications.
Ushering in a technological revolution that has changed the way we communicate
control and process data in a matter of few decades [88].
The basic structure of a FET is composed of a semiconducting channel
between two conductor pads known as source and drain. The channel is sandwiched
between the substrate and an overlying oxide layer. The oxide layer is coated with a
conductive layer to form what is known as a gate (Figure 7).

Figure 7: A typical top gated Si thin film transistor
Application of voltage on the gate controls the amount of current that flows
between the source and drain pads (due to the application of a source to drain
voltage). This mechanism allows the FET to be used as a variable resistor and a
switch. The growth of semiconductor industry led to the growth of thin film
fabrication industry as well, leading to the facilitation of the development of FETs
made entirely of thin films of metals/ semiconductors/ insulators. These thin film
transistors (TFTs) were first produced in 1965 [89]. They were made for scanning
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image sensors and were CdSe TFTs. The fabrication of TFTs on insulating substrates
helped in reduction of parasitic losses that were associated with the silicon substrate.
The patent by Edgar [86] describes the first thin film transistor. Under the normal
operating condition, a typical TFT, by the application of a voltage bias to the gate
electrode induces the accumulation of the electrons (in case of an n-type
semiconductor) in the semiconductor channel.

Figure 8: Different configurations of a TFT [1]
A simultaneous application of a Positive voltage to the drain results in a flow
of electrons from source to drain. The initial development of MOSFETs was much
rapid than TFTs, however, with the emerging technology and applications of TFTs
towards thin, flexible, large area electronics, sensing, smart labels, lighting, etc. this
field has rapidly caught up. Several configurations have been reported and developed
for TFT applications. These can be classified according to the device structure. There
are four types of FET structure – coplanar (top gated), coplanar (bottom gated),
staggered (top gated) and inverted staggered (bottom gated). The position of the gate,
source and drain electrodes with respect to the insulator and semiconductor layer
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(Figure 8) defines these differences. In a coplanar structure, all three electrodes are on
one side of the semiconductor layer. However, in a staggered structure, the gate
electrode is on one side of the semiconducting layer while the source and drain
electrodes are on the other side [90].

2.7.1

ISFET as a biosensor
Another form of FET that is commonly used in sensing applications is Ion

Sensitive FET or ISFET. First invented by Bergveld [91]. It is used for measuring ion
concentrations in a solution. The figure below shows the typical ISFET configuration.
It consists of a source and drain pads with a semiconducting channel encompassing
them. The channel is typically covered with a gate insulator such as SiO2, Si3N4,
Al2O3, etc. The channel and the gate insulator are then surrounded with a well to
enclose the solution under test. The gating action is achieved with the help of an
external electrode suspended in the solution. The solution acts as a gate electrode.
Presence of an ion layer between the substrate and the oxide layer results in a voltage
between them. The hydrolysis of OH bonds on the surface of the gate insulator varies
as the pH of the solution varies. Resulting in a change in the drain current. The
external electrode provides a reference potential against which the drain current can
be calibrated. Today ISFET based sensing devices have been used for various
applications. Rothberg et al. have shown an IC device for DNA Sequencing. The
device contains 1.2 million wells with ISFETs in them. They were able to sequence
three bacterial and a human genome using this device. Their device showed proton
sensitivity of 58mV/pH. Kiani Sasakia et al. [92] reported Graphene-based electrolyte
gated FET. They claimed that a label-free biosensor to measure enzyme activity was
possible using ISFETs, their device had sample volumes as low as 20 microliters.
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EGFET have been claimed to be an extension of traditional ISFET architecture by
Viera et al. [93]. They claim to have improved upon the ISFET design by isolating the
chemical environment from the FET and used this scheme to detect Glucose with a
detection limit of 0.027mM. Still, in another study, the sensor chips have been
integrated with a microfluidic channel to monitor potassium and pH levels [94].

2.7.2

Extended Gate FET
This configuration of FET is widely used for the fabrication of biosensors. It is

derived from the ISFET configuration of the FET [95].
In this configuration, the gate of the FET is connected externally to a
functionalized substrate. The substrate is often bound by a well to hold a specific
amount of liquid. An external electrode is dipped in the liquid. This electrode is
connected to an external supply that provides a voltage to the gate through the
externally connected substrate. The substrate serves as an ion sensitive site. This
configuration allows the active FET device to be isolated from the harsh chemical
environment and allows the device to function stably. Also, this configuration can
lead to a simple plug and play architecture enabling the user to discard the sensing
substrate when it is saturated or becomes nonfunctional.
This research will explore the use of MIP based sensing substrate along with a
commercially available FET for use in an EGFET configuration. The use of cortisol
specific MIP on an SPCE will allow the sensor to provide direct sensor readout (in the
form of drain current concerning cortisol concentration). The above configuration will
also address the challenges of label-free and repeatable sensing.
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2.8

Conclusion
Several techniques allow sensitive detection of cortisol in a sample. However,

most of the state of art techniques suffer from limitations that prevent their
widespread use. This chapter serves to introduce the reader to some of the common
cortisol detection methods and them with their main advantages and limitations. Some
techniques are introduced in the latter part of the chapter (CV, MIP, EGFET) that can
address the issues of the earlier recorded methods. The subsequent chapter will record
the developments and validation of a thin film based electrochemical immunosensor
for the detection of cortisol.

31

ELECTROCHEMICAL IMMUNOSENSING OF SALIVARY
CORTISOL.

3.1

Abstract
This chapter will discuss the development and validation of Au thin film based

electrochemical immunosensors for detection of cortisol. A self-assembled monolayer
of DTSP was functionalized on a thin film Au based IDEs. Cortisol specific
antibodies were then immobilized, and the non-binding sites were blocked using EA
on the SAM layer. The sensors were characterized at each layer using CV. The
fabricated immunosensors were characterized using different cortisol concentration.
These sensors were then validated by detecting cortisol in human saliva samples and
comparing the results with standard ELISA process. The fabricated sensors had a
detection range from 10 pg/mL to 100 ng/mL and a detection limit of 10 pg/mL.
These sensors performed well as compared to the ELISA results.

3.2

Introduction
Among the label-free technologies for biomarkers detection, salivary

electrochemical immunosensing has emerged as the most promising technologies for
POC cortisol detection systems. The cortisol concentration in saliva is lower than
total serum cortisol by a factor of 10, and the correlation between serum and salivary
markers is substantial [77] [96]. Salivary cortisol concentrations accurately reflect the
serum concentration at various times of day (morning, evening and around midnight)
[37]. Moreover, the salivary cortisol contains only free cortisol making protocol easier
[25]. Electrochemical immunosensing is based on the principle of measuring the
changes in electrical properties of a conductive material due to the adsorption of an
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analyte on the surface functionalized with antibodies [4, 8, 69]. The electrical change
is attributed to the change in the concentration of the electroactive redox species at the
electrode. The mature processing capability of the micro-fabrication industry has
allowed the building of microelectrodes that are highly sensitive and provide low
detection limits. The simplicity of electronic circuitry for electrochemical detection
and low-cost volume manufacturing has driven efforts to bring electrochemical
immunosensing up to speed with other immunosensing techniques [71, 72].
In recent years there have been many reports of electrochemical sensing of
cortisol using electrochemical impedance spectroscopy [80] and CV [97]. SAM [73,
81], Au nanowires [98], Au-PANI nanocomposite [99], and AgO@Ag-PANI
nanocomposite[4] based electrochemical cortisol immunosensor were reported.
Immunosensor were also integrated with microfluidic systems for POC sensing [74,
75].
These reports demonstrate a workable cortisol sensing system using
commercial cortisol sample. However, their application for field use is not explored
yet. In this paper, we report on the ability of the sensor to detect cortisol in saliva
samples of farm workers. IDEs functionalized with DTSP-SAM followed by covalent
immobilization of Anti-Cab were used to detect the concentration of cortisol present
in the saliva samples. The results obtained from the electrochemical detection were
validated through ELISA protocol currently in use.
This work aimed to establish a cortisol sensing protocol using saliva samples
collected from human subjects and its validation with the standard ELISA technique,
which was not reported earlier. This protocol will be used to understand the
behavioral change of farm workers on exposure to pesticides.
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3.3

Materials and Methods

3.3.1

Saliva sample Collection
Saliva samples were derived from a biologically-relevant sample of two

female agricultural workers of reproductive age who engage in shift-work. Evidence
indicates that cortisol levels vary significantly among female shift workers [70, 100102] and that stress associated with agricultural work is associated with cortisol level
variation [103-107], as is exposure to cortisol [108]. Farmworkers were 24 and 39
years of age and were recruited based on the following criteria: be at least 18 years of
age, and work in agricultural fieldwork, work early morning shifts, and have exposure
to pesticides. These samples were drawn from another study measuring the effects of
a behavioral study to assess pesticide exposures and stress response. Recruitment,
analyses and other procedures for this study were approved by the Human Subjects
Boards at the Penn State University and the Florida International University.
Samples were collected at awakening, before their first work break, at their
lunch break (before eating), upon arrival from work and before bedtime. Samples
were stored by participants’ at freezing (-20oC) until the project team transferred them
and stored at -80oC in the field lab. The standard protocol requires the storage saliva
samples to at -20oC or lower for the preservation of natural and biological properties
over extended periods and during transportation. Saliva samples were collected by
each farmworker using a Salivette (Sarstedt Inc., Rommelsdorf, Germany), which
consists of a small cotton roll inside a centrifuge tube. Each farmworker took the
Salivette home after receiving written and oral instruction on how to collect saliva.
Participants collected a saliva sample by chewing on the cotton roll for 60 seconds.
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The collected saliva samples were stored at -20oC to maintain its biological
characteristics. Before the sensing, the saliva samples were brought to room
temperature and centrifuged at 3500 rpm for 15 min to extract saliva from salivettes.
The separated saliva was then pipetted out and kept at -20oC when not in use. These
samples were further used to detect cortisol using electrochemical immunosensors and
ELISA.

3.3.2

Immunosensor Fabrication

3.3.2.1 Electrochemical Cleaning of IDEs
The IDEs (chamber volume ~5 µL, electrode width, and electrode gap 10 µm)
were procured from Micrux Technologies (Fig 1). The IDEs were electrochemically
cleaned prior to DTSP-SAM modification through performing CV, Autolab
Potentiostat/Galvanostat (Eco Chemie, Netherlands)] using 5 µL of 0.1 M H2SO4 as a
function of varying scanning cycles at a scan rate of 50 mV/S. The parameters of the
IDE cleaning process were optimized using CV techniques in 5 µL PBS (pH 7.4)
containing 5 mM K4[Fe(CN)6]3-/4- at a scan rate of 50 mV/s (Fig 2A). The magnitude
of the current response obtained was found to increase with increasing cleaning
scanning cycles (5-10). The higher current response was observed in the case of IDEs
cleaned using 9 cycles and higher. However, the electrode started to etch after 9
scanning cycles. Thus, IDEs were cleaned using 7 scanning cycles in 5 µL, 0.1M
H2SO4. All IDEs were cleaned using the same process and exhibited identical current
response (within ~ 2% variation, Fig 2B) without morphological damage.
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3.3.2.2 Fabrication of DTSP-SAM onto IDEs and Electrochemical Cortisol
Immunosensing
DTSP, Sodium Borohydride (NaBH4), monoclonal anti-cortisol antibody
(Anti-Cab), Cortisol and all other chemicals were purchased from Sigma-Aldrich and
were used without any further purification. For fabrication of DTSP-SAM, the IDEs
were immersed in 2 mg/mL solution of DTSP in acetone for 2h. During the SAM
fabrication, DTSP was reduced using NaBH4 (10 mg/mL in DI water). After SAM
modification, all DTSP/IDEs were rinsed with acetone and then by DI water to
remove unbound DTSP particles. Anti-Cab (5 µL) was covalently immobilized via a
facile reaction between the amino group of antibodies and reactive succinimidyl
group of the DTSP SAM surface. The DTSP-SAM/IDE were incubated with Anit-Cab
for 2hrs followed by carefully washing with PBS (pH 7.4, 10 mM) to remove any
unbound molecules [74]. Phosphate buffer saline (PBS) solution (10mM, pH 7.4) was
prepared by dissolving 1 PBS tablet in 200 mL of de-ionized (DI) water and used to
prepare the Anti-Cab (1mg/mL) and cortisol solutions. The non-binding sites of AntiCab/DTSP/IDEs bioelectrode were blocked using 5 µL of EA. The incubation time
was 10 min.

EA/Anti-Cab/DTSP/IDEs were washed with PBS and stored in a

refrigerator at 4oC when not in use. The fabrication of SAM onto IDEs and
immunosensor development is shown in Figure 1A.
3.3.2.3 Measurement of Cortisol
The fabricated EA/Anti-Cab/DTSP-SAM/IDEs immunoelectrodes were used to
detect the various concentration of cortisol using CV techniques in 5µL PBS (pH 7.4)
containing 5 mM [Fe (CN)6]3-/4- as redox moieties. The pH of 7.4 was chosen for
electrochemical response studies of immunosensor, as this is the recommended pH for
biomolecules to presume higher biological activity [73]. The electrochemical and
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immuno-chemical reaction on IDEs surface is shown Figure 1B. The fabricated
immunoelectrodes were used to detect cortisol in saliva samples of two specimens
collected at different time intervals. 5 µl of saliva sample was placed on the
electrochemical immunosensor. The saliva sample was incubated for 30 minutes on
the sensor to ensure proper binding. Immunoelectrodes were then washed using PBS
~10 mL to remove unbound saliva.
Cortisol Enzyme Immunoassay Kit was procured form Arbor Assays, MI and
a standard protocol were adopted to detect saliva cortisol. In Brief, 50 µl of 4X diluted
saliva was used for the detection of cortisol.

3.4

Results and Discussions

3.4.1

Electrochemical Characterization
CV technique was used to optimize the step-wise fabrication of

electrochemical immunosensor which is utilized to detect cortisol. Figure 9 shows the
results of the CV studies for IDEs (a), DTSP-SAM/IDEs (b), Anti-Cab/DTSPSAM/IDEs immunoelectrode (c) and EA/Anti-Cab/DTSP-SAM/IDEs (d) in 5µL PBS
(pH 7.4) containing 5 mM Fe(II)/Fe(III) at 50 mV/s in a potential range from -0.6 to
0.6 V. CV of IDEs exhibited a well-defined oxidation and reduction peaks of redox
moieties present in the electrolyte. The magnitude of electrochemical current response
decreases after modifying IDEs by DTSP-SAM. This suggests that SAM hinders the
electron transport from Fe(II)/Fe(III) to IDEs due to strong Thiol bonding between
DTSP-SAM and Au of IDEs which indicates successful DTSP-SAM fabrication.
After the immobilization of Anti-Cab, the magnitude of current from DTSPSAM/IDEs further decreases due to the covalent binding between Anti-Cab and DTSP
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via amide bond formation. The magnitude of current from EA/Anti-Cab/DTSPSAM/IDEs

immunoelectrode

was

lower

than

Anti-Cab/DTSP-SAM/IDEs

immunoelectrode. This reduction of current is a clear indication that the nonconducting EA blocks the non-binding sites on immunoelectrode and reduce the
electron transport from the electrolyte to IDEs.
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Figure 9: CV studies of IDEs (a) DTSP-SAM modified IDEs (b), Anti-Cab
immobilized DTSP-SAM/IDEs electrode (c), and EA immobilized Anti-Cab/DTSPSAM/IDEs immunoelectrode (d) using 5 µL PBS (pH 7.4) containing 5 mM
[Fe(CV)6]3-/4- at 50 mV/s.
The CV studies of electrodes and immuno-electrodes have been performed as
a function of scan rate (10-100 mV/s). A linear relationship between the magnitude of
oxidation/reduction current and the square root of scan rate (data not shown) has been
observed for all electrodes. This confirms that the assay is a linear-diffusion-driven
process. It obeys Randles-Sevcik equation ip = (2.69x105) n2/3ACD1/2v1/2, where n is
the number of transferred electrons, A is the active area of the electrode, C is the bulk
concentration of the redox species, D is the diffusion coefficient, and v is the scan
rate[109]. The magnitude of the current response is also linearly related to differences
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in potentials revealing the facile electron transport from the electrode to the IDE
surface.

3.4.2

Electrochemical Response Studies of Cortisol
Electrochemical response studies of developed DTSP-SAM-modified IDEs

immunosensor as a function of cortisol concentration (10 pg/mL to 100 ng/mL) was
performed using CV technique in 5 µL PBS (pH 7.4) containing 5mM [Fe(CN)6]3-/4with a potential range of -0.6 to 0.6 V at a scan rate of 0.5mV/s. Prior to
electrochemical measurement, 5 µL of each cortisol sample was incubated on the
immunosensor surface for 30 mins for complete binding of Anti-Cab with standard
cortisol solution. A washing step using 30 µL of PBS was performed to remove the
unbound cortisol from the sensor surface. All the CV measurements were performed
in triplets. The result of CV studies indicates that the magnitude of current response
decreases on the addition of cortisol due to the formation of insulating immunocomplex between Anti-Cab and cortisol which further inhibit the electron transport
from the electrolyte to IDEs surface (Figure 10).

Figure 10: Electrochemical response of EA/Anti-Cab/DTSP-SAM/IDEs
immunoelectrode after addition of standard cortisol solution
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A calibration curve (Figure 11) plotted between the magnitude of current response
and logarithm of cortisol concentration was found to be linearly dependent and follow
the equation [Y = 1.5 × 10-5 + 6× 10-6 log (Cortisol concentration); R = 0.99]. The
fabricated EA/Anti-Cab/DTSP-SAM/IDEs immunosensor exhibited linearity in the
range of 0.1 to 100 ng/mL, a detection limit of 10 pg/mL, a sensitivity of 6
µA/(pg/mL) with the regression coefficient of 0.99 and standard deviation of 0.6 A.

Figure 11: Calibration curve plotted between the magnitudes of current response
obtained and logarithm of cortisol concentration (10 pg/mL to 100 ng/mL)
The confirmation of Anti-Cab onto DTSP-SAM/IDEs electrode and its affinity
with cortisol was understood through the association constant (Ka, 3 × 1012 L mol−1)
between Anti-Cab and cortisol, calculated using Lineweaver–Burke-like plot. Ka value
greater than 1011 is accepted as a demonstration of high affinity [110]. Figure 12
shows the results of the CV studies of EA/Anti-Cab/DTSP-SAM/IDEs immunoelectrode with respects to interferents such as PSA (100 pg/mL), NSE (100 pg/mL),
EGFR (100 pg/mL) and BSA+Cortisol (100 pg/mL) with respect to cortisol (100
pg/mL). The interferents were dispensed on the immunosensor (EA/AntiC40

Abs/DTSP-SAM/μIDEs), and their electrochemical response was measured. The
change in electrochemical response of the interferents was compared to that of the
immunosensor, and it was found to be of the order of 1-2%. As compared to the
change in the response of Cortisol signal, which was in the order of 13-14 %, the
effects of interferents can be conveniently neglected. This demonstrates that the effect
of interferents on EA/Anti-Cab/DTSP-SAM/IDEs immunosensor is minimal and the
antibodies are selective to the cortisol molecule. A CV study was also carried out to
study the shelf life of the EA/Anti-Cab/DTSP-SAM/IDEs immunoelectrode at
intervals of 1 week (data not shown). The results of the study showed electrodes were

Change in Electrochemical Response (%)

stable for 28 days and beyond that time the electrochemical response reduced.
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Figure 12: CV studies of EA/Anti-Cab/DTSP-SAM/IDEs immuno-electrode with respects
to interferents such as PSA (100 pg/mL), NSE (100pg/mL), EGFR (100pg/mL) and
BSA+Cortisol (100 pg/mL) with respect to cortisol (100 pg/mL)
3.4.3

Electrochemical Immunosensing of Saliva Cortisol
The IDEs based electrochemical immunosensor for cortisol sensing was

utilized for testing of cortisol concentrations in saliva samples. 05 µL of the saliva
sample was incubated on the electrochemical immunosensor for a period of 30 mins.
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A washing step using 30 µL of PBS was performed to remove the saliva and any
unbound cortisol from the sensor surface. 5 µl of Ferri Ferro solution was then used to
perform CV. The electrochemical response studies of EA/Anti-Cab/DTSP-SAM/IDEs
immunoelectrodes carried out using CV in 5 µL of PBS containing 5mM Fe(II)/
Fe(III) as the redox probe at a scan rate of 50 mV/s. A very significant change in
current response of immunosensor is observed on adding each saliva samples.
Cortisol concentration was read using the calibration curve developed in
electrochemical response studies (section 3.2).

All samples were measured in

triplicates, and the average was computed to validate with the ELISA technique as
presented in Table 1 and Table 2.
Table 1: Cortisol Values as measured in saliva samples using the developed
immunosensor
Sample

Saliva Collection
Time and Date

A

3/26/2013 (9:47AM)
3/27/2013 (10:00AM)
3/27/2013 (10:03PM)
3/28/2013 (2:00AM)
3/26/2013 (10:13AM)
3/27/2013 (1:42AM)
3/27/2013 (10:13AM)
3/28/2013 (3:02AM)

B

Measured
Electrochemical
Response (µA)
7.16
7.38
12.23
8.89
5.24
7.76
4.26
9.17

Cortisol Concentration
(Obtained Concn. x 2.2)
(nMol/L)
3.63
3.81
0.90
1.818
9.09
2.727
14.54
1.93

Final Cortisol
Concentration
(ng/dL)
131.78
138.37
32.94
65.89
329.45
98.83
428.29
69.18

Table 2: Cortisol Values measured in saliva samples using Cortisol ELISA kit
Sample

Saliva Collection
Time and Date

A

3/26/2013 (9:47AM)
3/27/2013 (10:00AM)
3/27/2013 (10:03PM)
3/28/2013 (2:00AM)
3/26/2013 (10:13AM)
3/27/2013 (1:42AM)
3/27/2013 (10:13AM)
3/28/2013 (3:02AM)

B

Measured
Response (4x
dilution)
(%B/Bo)
64.133
66.909
56.113
81.758
41.705
99.559
40.956
96.695
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Cortisol Concentration
(pg/mL) 4X dilution

389
360
594
182
995
125
1187
87

Final Cortisol
Concentration
(ng/dL)
155.6
144
237.6
72.8
398
50
474.8
34.8

3.4.4

Detection of Salivary Cortisol using ELISA
Saliva samples from the same salivette were tested for cortisol using ELISA

(Arbor Assays, MI). This was done to validate the results obtained from the
electrochemical immunosensor. The protocol prescribed by the ELISA kit vendor was
followed for cortisol detection in saliva samples. A calibration curve for cortisol
measurement was established, the assay was performed in a 96-well titer plate
consisting of six known standard cortisol concentrations (100, 200, 400, 800, 1600
and 3200 pg/mL) and the saliva samples. The calibration curve obtained from the
measurement of the standard solutions is presented in Fig 6. Next, the saliva samples
were diluted 1:4 in the provided assay buffer and 50 µL of saliva samples were
utilized for each measurement. Saliva samples from each of the salivettes were tested
in triplicate sets, and the average value was utilized to determine the final cortisol
concentration and is presented in
Table 2. Figure 13 presents the comparison of results obtained for cortisol
detection in saliva samples tested using the electrochemical immunosensor and
ELISA. The trend observed for the electrochemical measurements were mostly
consistent with that obtained from ELISA, except for the saliva sample from
Specimen A [3/27/2013 (10:03pm)], in which the ELISA value was observed to be a
high value at night time. This observed difference may be due to an experimental
error of denatured saliva sample.
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Since both methods have different transduction techniques to detect cortisol
concentration, the results were in different magnitudes. To compare and correlate
these responses, one was scaled to the other. All values of cortisol concentration
obtained from the corresponding electrochemical calibration curve were adjusted by a
factor of 2.2 to compare them with values obtained using ELISA assays. A good
correlation was achieved between the two sets of data, thus enabling quantitative
validation of the electrochemical immunosensing of Cortisol in a biologically relevant
fluid such as saliva.

Figure 13: Comparison of cortisol concentration measured by ELISA and
Electrochemical measurement on saliva samples from Specimen A & B at specific
time intervals over three days.
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3.5

Conclusions
The electrochemical immunosensing platform was utilized for a low-cost and

label-free detection of cortisol via covalent immobilization of Anti-Cab onto DTSPSAM-modified IDEs (chamber volume 5 µL, electrode width 10 µm and electrode
gap 10 µm). The fabricated electrochemical immunosensor exhibited a detection
range from 10 pg/mL to 100 ng/mL, a detection limit of 10 pg/mL, and a sensitivity of
6 µA/(pg/mL) with the regression coefficient of 0.99. The sensor has been used for
salivary cortisol detection in clinically relevant samples, and sensing performance has
successfully validated using conventional ELISA method. The cortisol value in saliva
samples of two specimens collected at different time intervals using DSTPSAM/IDEs correlates (within 2-5%) with those obtained using ELISA. The developed
sensor can reliably detect cortisol in saliva within a physiological range which can be
used as a marker to understand various physical, behavioral and psychological
variables which may affect the central nervous system.
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NANO ENABLED SIGNAL AMPLIFICATION IN SAM BASED
ELECTROCHEMICAL CORTISOL IMMUNOSENSORS

4.1

Abstract
Electrochemical immunosensors function by measuring the changes in the

electrical properties such as current, potential, conductance, capacitance, and
impedance during an immunochemical reaction between antigen (target molecule)
and the antibody [111, 112]. Although capacitive and impedimetric immunosensors
can be directly utilized to investigate the antibody-antigen interaction without the
need of other reagents and separation steps, their analytical sensitivity is limited in
clinical applications. Amperometric immunosensors based on the measurement of
currents resulting from the electrochemical oxidation or reduction of electroactive
species has attracted more interests for high sensitivity and low complexity
instrumentation [112]. However, amperometric immunosensors requires labeling of
either antigen or antibody, since both the reaction partners are electrochemically inert.
Labeling is a time-consuming process, costly and denatures the biomolecules.
Amperometric immunosensors that utilize an electrolyte solution containing
reversible redox species have been widely used as mediator probes instead of labeling
antibodies/antigens; however, this causes

electrode contamination, reagent-

consumption and operation inconvenience., label-free amperometric immunosensors
have been proposed to address the above issues. One possible way to achieve labelfree sensing was by integrating of signal generating probe on electrode surfaces itself.
This was achieved by electrochemical fabrication of Copper based nanoparticles on
SPCE working surface.
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4.2

Introduction
The use of nanomaterials as signal generating probes for electrochemical

detection of biomarkers have been reviewed earlier [111]. However, the selection of
signal generating probe is vital for electrochemical immunosensor, especially for
label-free electrochemical immunosensor, since it is responsible for three major tasks:
(i) being redox active and produce electrochemical signals for corresponding
immunocomplex formation, (ii) increasing specific surface area of electrode to
immobilize more antibodies and (iii) improving conductivity for sensitive detection of
antigen. For electrochemical devices, nanoparticles, carbon nanotubes, and graphene
have been used to catalyze electrochemical reactions and to improve electron transfer.
Nanoparticles, especially have also been used as labels to generate an intense signal in
comparison with electroactive molecules or organometallic complexes like ferrocene.
Indeed, due to their high number of atoms, a large number of electrons can be
exchanged through oxidation or reduction.
Group 11 metals (Cu, Ag, and Au), which are very weak chemisorbing agents,
often display marked catalytic and electrocatalytic properties. Some types of copper
electrodes showed an excellent electrocatalytic activity for DNA detection without
observable self-poisoning. Copper electrodes undergo oxidation at unexpectedly low
potentials, typically within the so-called double layer region, to form surface-bonded
copper (I) hydrous oxide species.
A reagent-less and label-free voltammetric immunosensing strategy was
demonstrated by employing a nanomaterial integrated electrode as a signal generating
probe. Copper/copper oxide (Cu/CuxO) nanoparticles integrated SPCE were used to
construct the immunosensing platform. The stress biomarker, cortisol was employed
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as a model analyte. Cortisol specific monoclonal antibodies (C-Mab) were covalently
immobilized on the surface of the Cu/CuxO-SPCE functionalized with DTSP-SAM.
The formation of Cu/CuxO nanoparticles on the surface of SPCE was characterized by
SEM and XRD analysis. The redox signal of the Cu/CuxO nanoparticles could be
detected directly through CV and used as signal generation probe for the direct
detection of cortisol. The formation of immunocomplexes leads to a decrease in the
electrochemical redox signal of Cu/CuO nanoparticles. This was due to the increased
spatial blocking of the electrode surface. The proposed immunosensing strategy
allows a rapid and sensitive means of cortisol analysis with a limit of detection of
about 1 pg/mL. The Cu/CuxO platform can be further applied for designing other
label-free immunoassays.

4.3

Experimental

4.3.1

Materials and methods
SPCE from Zensor was used for the construction of biosensor. The thiol-based

crosslinker, DTSP, and sodium borohydride (NaBH4) were purchased from Thermo
Fisher Scientific. Copper (II) Chloride (CuCl2), Potassium chloride (KCl) and
Sodium Hydroxide (NaOH), used for deposition of copper nanoparticles were
purchased from Sigma Aldrich. The buffer solution used for characterization was
prepared from sodium phosphate monobasic (NaH2PO4) and sodium phosphate
dibasic (Na2HPO4), also purchased from Sigma Aldrich. All the chemicals were of
analytical grade and were used without further purification.
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4.3.2

Measurement and apparatus
CV and amperometry were employed using a potentiostat from CHI

Instruments Inc. Electrochemical Instrumentation (Austin, TX, USA) to record the
amperometry and voltammetry plots. The three-electrode configuration system used
in this work consisted of a carbon working electrode and silver reference electrode
and an external Pt mesh as a counter electrode. This was placed at the bottom of a 6
ml electrochemical cell for cleaning and deposition with constant stirring through a
magnetic stirrer on a heater under different temperature variants. SEM images of the
nanostructures on the sensor surface were taken using SEM 6330/JEOL FE-SEM

4.3.3

Electro-synthesis of copper nanostructures
Before carrying out the nano-assembly on to the SPCE, the working electrode

surface of SPCE was electrochemically pretreated by immersing it in 0.1 M H2SO4
and cycling the potential between - 0.5 and 1.0 V at 100 mV/s. The primary purpose
of this pretreatment was to remove organic ink constituents or contaminants and to
increase the surface roughness of the SPCE. After pretreatment, the SPCE was
washed well with deionized water and dried in air. Amperometry was used for the
electro-deposition of copper nanoparticles onto the working electrode of SPCE. Cu
nanoparticles were deposited onto the electrode at a constant potential, and then they
were oxidized into CuO by potential cycling. Briefly, a constant potential of -0.35 V
was applied to the electrode in the precursor solution of 0.1 M KCl and 0.01 M CuCl2
which had been pre-purged with N2 for 15 min. The electrode was then rinsed several
times with water and dried with a flow of N2 before it was repeatedly scanned in a 0.1
M NaOH with CV under the potential range of -0.5 to 0.3V at 100 mV/s for 20 cycles,
allowing the Cu nanoparticles to be oxidized into CuO nanoparticles. This was
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followed by rinsing in DI water and characterization in 0.1M PBS after purging with
N2.

4.3.4

Biosensor fabrication and enzyme immobilization
Formation of a self-assembled monolayer (SAM) of DTSP on the metal

nanostructure integrated SPCE followed by anti-cortisol antibody immobilization.
DTSP solution (10 mg/ml) was prepared using acetone and incubated on the electrode
for 2hrs for SAM formation where the enzyme was covalently immobilized with
DTSP via crosslinking. DTSP solution was first reduced using NaBH4 and then
dispensed on the nano-material integrated electrodes at room temperature for SAM
formation. The DTSP SAM-modified electrodes were then rinsed with acetone to
eliminate any unbound DTSP followed by cleaning in DI water. [12] Cortisol
antibodies were then covalently attached to the SAM-modified electrode by dropcasting with 100ul of anti-cortisol antibody solutions It is from the facile reaction
between the amino group of the antibody and reactive succinimidyl group of the
DTSP on the SAM surface below, that the covalent binding results [13]. The nonbinding sites of Ab/Cu-CuO/SPCE bioelectrode were obstructed by immobilizing
10μL of bovine serum albumin (BSA) for an hour followed by rinsing in PBS and
dried with N2 at room temperature.

50

4.4

Results and discussion

Figure 14: CV of copper nanoparticles being overoxidized for three cycles

Figure 15: SEM image of the copper Oxide Nanoparticle deposited SPCE. The Particle size
ranges from ~150nm.
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The Copper Oxide nanoparticle modified SPCE was characterized by CV
using the potentiometer form CHI instruments. The CV scans in Figure 14 show the
overoxidation of copper nanoparticles to copper oxide at potentials higher than 0.5 V
over three cycles. With each subsequent cycle the overoxidation potential shifts
towards the higher side, and at the end of the third cycle, it is observed to be at 0.6 V.
The resulting copper oxide nanoparticles were characterized by SEM [JEOL
JSM-6330F FESEM]. Figure 15 shows the SEM image of the CuO modified SPCEs
showing the dispersion of nanoparticles. XRD studies of the nano-functionalized
electrode surface show the presence of Copper and Copper Oxide peaks.
The SEM image in Figure 15 shows the uniform distribution of copper oxide
nanoparticles on the SPCE. The estimated average particle size is ~150 nm. The
XRD graph in Figure 16 shows the presence of a prominent copper peak and smaller

Figure 16: XRD image of Copper/ Copper oxide nanoparticles on the SPCE
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copper oxide peak. This indicates the formation of a core-shell structure of a CuO/Cu
nanoparticle. The core of nanoparticle consists of Cu surrounded by a shell of CuO.
The fabricated immunosensors were used to detect the various concentration of
cortisol using CV with PBS as the electrolyte. The CV scans for PBS shows the
oxidation response current at 431 µA. After the Anti-cortisol antibody
immobilization, the magnitude the oxidation current response went down to 213 µA.
this indicates successful binding of the antibodies to the sensor surface. The reduction
in current response can be explained due to the hindrance in electron transport caused
by the insulating nature of the antibodies. The electrochemical response current of the
fabricated immunosensor was studied in PBS (pH-7) as a function of cortisol
concentration. Figure 18 shows the oxidation peak current of immunosensor from
cortisol Concentrations of 100µM to 1pM. The decrease in the magnitude of
electrochemical oxidation response can be explained due to the formation of cortisol
and anti-cortisol antibody immunocomplex. This hinders the electron transport from
the surface of the electrode to the electrolyte. A calibration curve of the current
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response to the logarithmic cortisol concentration has been plotted in Figure 17. The
curve reveals a linear correlation from 100 µM to 100 pM with a sensitivity of 4.21
µA/M and the standard deviation of 0.0094. The formula 3xSD/m was used to
estimated Limit of detection, which was found to be 6.6nM

Figure 17: Concentration curve of the Cortisol immunosensor showing
linear concentration from 10 M to 10 nM samples of cortisol.

Figure 18: Different concentration of cortisol dispersed on the immunosensor
and their oxidation response current.
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4.5

Conclusion
A label-free immunosensor specific to cortisol using Copper/copper oxide

nanoparticles

was

successfully fabricated on the

SPCEs. The

fabricated

immunosensor was characterized by CV, SEM, and XRD. The sensors were used to
detect the different concentration of cortisol with PBS as the electrolyte medium. The
sensitivity of the fabricated sensor was determined to be 4.21 µA/M and the limit of
detection 6.6 nM. Though this research enables the label-free immunosensing of
cortisol, it has some inherent challenges associated. The Antibodies are temperature
dependent and limit the shelf life of the sensors. The cost associated with the
fabrication of immunosensors is high due to the expensive nature of antibodies. The
next chapter seeks to investigate polymers for electrochemical detection of Cortisol.
This new technique aims to make the sensor cost effective, temperature stable and
make repeatable measurements possible with the same sensor element.
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BIO-MIMETIC SENSOR FOR LABEL-FREE DETECTION OF
CORTISOL USING MOLECULARLY IMPRINTED POLYMERS APPROACH

5.1

Abstract
We report here, an in situ electro-polymerized MIP based electrochemical

sensor for the detection of cortisol. Cortisol specific MIP films were prepared by
electro-polymerizing pyrrole monomer on the electrode surface in the presence of
cortisol as a template molecule. After eluting the cortisol through electrochemical
overoxidation, cortisol specific imprinted sites created on the polymeric matrix were
used to detect cortisol using a redox mediator Fe(II)/Fe(III). The imprinted matrix was
characterized using CV and scanning electron microscopy (SEM). The effect of
current responses on electro-polymerization cycle, monomer concentration, elution
cycles (target removal), pH of the supporting electrolyte, and rebinding time was
investigated and optimized. The MIP based cortisol sensor exhibited a detection limit
of 1 pM L-1 cortisol. Moreover, the sensor showed good selectivity and reusability the
sensitivity remained >90% after 7 cycles of elution/rebinding, while the sensitivity
only decreased to 90% after 4 weeks of storage at room temperature. The reusable
MIP sensor has been applied to detect cortisol in real samples and validated with
ELISA. These features make the MIP based cortisol sensing attractive for reusable
and continuous cortisol monitoring applications.

5.2

Introduction
Current,

analytical

methods

such

as

ELISA

and

electrochemical

immunosensors are widely used to detect cortisol [77, 83, 113-115]. These analytical
techniques involve the use of cortisol specific antibody as a biorecognition element
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and provide selective detection of cortisol. However, instability of antibodies, the
need for refrigerated transport and storage, and the high cost of producing immunereagents are the severe roadblocks to the commercialization of immunosensor for
point-of-care (POC) applications [78, 116]. Therefore, the design and synthesis of
artificial receptor systems as stable mimics to the conventional antibodies with high
target binding affinity is in demand for diagnostic applications. One technique that is
being increasingly adopted for the generation of artificial bioreceptors is molecular
imprinting [117, 118].
Molecular imprinting is a technique for creating specific recognition sites in
synthetic polymeric matrices that are structurally complementary to target molecules.
MIPs are synthetic polymers having recognition sites selective towards the target
analyte. They are versatile, stable and cost-effective substitutes for the natural
antibodies [119-122]. They have a considerable impact and potential applications in
biosensor commercialization owing to their number of merits such as low cost, easy
storage, and applicability in harsh conditions. MIPs possess longer lifetimes over the
enzymes, antibodies, and proteins [123-126]. Another attractive feature of MIP based
biosensor is its reversible binding with the target analyte, which makes the MIP
sensors reusable where frequent/continuous monitoring is required.
Traditional

polymerization

techniques

such

as

bulk

polymerization,

precipitation polymerization, and emulsion have been widely used for the synthesis of
MIPs. However, controlled integration of MIPs onto the transducer surface still
remains a challenge. Electrochemical polymerization is an attractive method for
patterning

MIPs

directly

onto

the

surface

of

biochips.

Moreover,

the

electropolymerization process allows us to control the thickness, morphology, and
reproducibility of MIP films by tuning the experimental parameters such as the
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concentration of target/monomer, polymerization cycles, and applied potential [127130]. Various electroactive monomers, such as pyrrole, aniline, and ophenylenediamine were explored as potential materials for synthesis MIPs by
electropolymerization. Among them, polypyrrole (PPy) based MIP has received
interest because of its facile electropolymerization, high conductivity, and stability in
ambient conditions [131-133]. In the past years, attempts were made to synthesize
MIPs for separation of cortisol [134-136]. However, no attempts were made to obtain
an in situ fabricated MIPs for the electrochemical detection of cortisol. In this work,
for the first time, we report a facile electrochemical strategy to fabricate a stable
cortisol MIP sensor using PPy. One of the key aspects in designing reproducible MIP
biosensor is controlled removal of template molecule from the polymer matrix. To
remove the entrapped template molecule from the polymeric matrix, different
strategies have been performed. The first and most straightforward approach is
extraction with an appropriate solvent. In some cases, the target extraction involves
temperature, microwave, or ultrasonic assisted approaches to increase the rate of
extraction. However, these methods cause imprinted cavities to distort and,
consequently, makes the MIPs less efficient towards rebinding and selectivity [137].
In the current work, an electrochemical elution approach was performed using CV to
extract the cortisol from the polymeric matrix. The effect of electrochemical
extraction cycles on the template removal was also investigated.
Moreover, we demonstrate an efficient and fast protocol for removing the
template cortisol from the polymeric matrix, which improves the facile fabrication
cortisol imprinted biosensor. The biosensor was then applied to detect human salivary
cortisol levels, and the results were validated using the ELISA technique.
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5.3

Experimental

5.3.1

Materials
Pyrrole monomer (≥98%), potassium ferricyanide (K3[Fe(CN)6]), potassium

ferrocyanide (K4[Fe(CN)6]), potassium chloride was purchased from Sigma-Aldrich
Co., USA. Phosphate buffer solution (PBS) (0.1 M, pH 7.2) was prepared by
dissolving 1 tablet in 200 mL of de-ionized (DI) water. A stock solution of cortisol
was prepared by dissolving 1 mg of cortisol in 1 mL of ethanol. Working aliquots
were prepared by diluting the cortisol stock solution with PBS. A standard stock
solution of K3[Fe(CN)6])/ K4[Fe(CN)6] (5 mM) was prepared in PBS. Cortisol
enzyme immunoassay kit was procured from Arbor Assays, MI and a standard
protocol were adopted to detect saliva cortisol. In Brief, 50 µl of 4X diluted saliva
was used for the detection of cortisol. All other reagents were of analytical grade and
solutions were prepared using double distilled water.

5.3.2

Preparation of MIP and non-imprinted polymer (NIP) modified electrodes
Prior to the electrosynthesis of MIP, the SPCE was cleaned to remove organic

ink constituents/contaminants and to increase surface roughness. The pre-treatment of
the SPCE was carried out by cycling the potential between -1.5 V to 1.5 V at a scan
rate of 100 mV/s in 0.1 M H2SO4 for 10 cycles [111, 138]. The SPCE was then
washed with deionized water and dried at room temperature. The electrosynthesis of
MIP films was performed using CV by cycling the potential range between 0 and 0.9
V at a scan rate of 50 mV/s for 10 cycles in 0.1 M PBS containing 0.8 M pyrrole and
0.1 M KCl. 10 mM cortisol was added to the solution as a template molecule before
the polymerization. As the polymer matrix grows on the working electrode, cortisol
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molecules diffuse toward the electrode surface and get entrapped in the polymer
matrix.
After the polymerization, polymerization, the entrapped cortisol molecules
were extracted from the conducting polymer matrix to produce a surface
complementary in shape and functionality to the original template, cortisol. The
extraction was performed through over-oxidizing the PPy by cycling the potential
range between -0.2 to 0.8 V for 40 cycles in 0.1 M PBS solution. The identical
procedure (polymerization followed by overoxidation) was used to fabricate NIP
electrode but without adding cortisol as a template. Modified electrodes were then
dried under nitrogen flow and stored at room temperature.

5.4

Cortisol sensing using MIP
The electrochemical detection of cortisol by the MIP sensor was performed by

placing 5 µL of an appropriate concentration of cortisol solutions at the working
electrode, for 10 min without stirring. The sensors were washed with water to remove
any material that may have been absorbed on the surface. Subsequently, the
electrochemical measurements were carried out in the presence of 40 µL of 5 mM
K3[Fe(CN)6]/K4[Fe(CN)6] solution containing 0.1 M PBS at room temperature.

5.5

Results and Discussion

5.5.1

Fabrication of cortisol MIP and NIP electrodes
Formation of cortisol specific MIP films on the electrode surface was achieved

by electrochemical polymerization of pyrrole in the presence of cortisol. The polymer
growth was monitored through the changes in the current response obtained during
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polymerization cycles. The voltammograms obtained during electro-polymerization of
pyrrole in the absence (dotted lines) and in the presence of cortisol (solid lines), from
0 V to 0.9 V at 50 mV/s using 0.1 M KCl as supporting electrolyte are compared in
Fig. 1A. In both the cases, the oxidation currents were increased remarkably at each
voltage sweep, suggesting a controlled growth of the polymer, suggesting the
thickness of the polymer film can be controlled by the regulating the scan cycles.
During the polymerization, cortisol molecules diffuse towards the electrode and bind
to the PPy conducting matrix through hydrogen bonding (Scheme 1). Although the
two voltammograms look similar in shape, the capacitive currents observed for the
electropolymerization in the presence of cortisol (solid lines) is significantly higher
than those obtained in its absence (dotted lines). The increased capacitive current of
the polymer film in the presence of cortisol confirms the binding of cortisol, an
electro-inactive molecule, with the polymer.
Removal of cortisol templates from the polymeric matrix is necessary to form
complementary imprinted sites for the subsequent rebinding. The electrochemical
over-oxidation process was used to remove cortisol molecules from the PPy matrix.

Figure 19: CV scans taken during the electropolymerization of pyrrole in the absence
(dotted lines) and in the presence (solid lines) of 10 mM cortisol onto the SPCE.
Scan rate: 50 mV/s.
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The polymer matrix was over-oxidized by scanning the potential in a range of -0.2 V
to +0.8 V for 40 cycles in 0.1 M PBS at a scan rate of 50 mV/s (Figure 19). For
clarity, the initial five scans were shown in Figure 20. During the elution scans, a
broad irreversible voltammetric peak was observed at ~ 0.3 V due to the
overoxidation of PPy (Li and Qian, 2000). As seen in Figure 20, no cathodic peak was
observed during the reverse scan, which indicates that the over-oxidation of PPy is
electrochemically irreversible. The above process causes the removal of cortisol from
the PPy matrix while oxygen-containing groups, such as carboxyl, are incorporated
into the polymer backbone. The decrease in the current response during subsequent
scan cycles is due to a decrease in conductivity of the PPy film. Since the overoxidation was performed here in a neutral condition, the degradation of PPy matrix
was avoided. The NIP fabrication process involves the same protocol as used to
fabricate MIP (polymerization followed by overoxidation) but without the addition of
cortisol as a template.

Figure 20: Recorded voltammograms during the elution of cortisol from the PPy matrix
at 0.1 M PBS; scan rate of 50 mV/s.
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5.5.2

Electrochemical characterization of cortisol specific MIP
The electrochemical behavior of stepwise fabrication of cortisol MIP sensor

was studied in 5 mM K4[Fe(CN)6]/K3[Fe(CN)6] solution containing 0.1 M PBS. The
results are shown in Figure 21. The CVs of [Fe(CN)6]3-/[Fe(CN)6]4- redox probe was
chosen as a marker to investigate the changes in the electrode behavior after each step
of the sensor assembly. As shown in curve (a), well-defined reversible redox peaks
for the [Fe(CN)6]3-/[Fe(CN)6]4- redox couple were observed with bare SPCE. The PPy
modified SPCE showed an apparent increase in the peak current for the redox probe
along with the increase in capacitive currents (curve b). This was attributed to the
increase in active surface area by conducting PPy matrix on the SPCE surface. The
permeability of the porous PPy film is also responsible for the increased electron
transport kinetics. [Fe(CN)6]3-/[Fe(CN)6]4- is an anion; due to the electrostatic
interactions, the [Fe(CN)6]3-/[Fe(CN)6]4- ions inserts easily into the positively charged
PPy film and thus involved in rapid electron transfer kinetics. The peak current
response observed for cortisol loaded PPy matrix (curve (c)) was much lower than the
one observed for PPy matrix without cortisol (curve (b)). This confirms that cortisol
was effectively loaded onto the PPy matrix and hinders the electrochemical response
of [Fe(CN)6]3-/[Fe(CN)6]4-.
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It is interesting to note that, removal of cortisol from the PPy matrix
drastically decreases the current response of the redox probe (curve (d)). The voltage
induced overoxidation leads to conductivity loss in PPy due to the introduction of
carbonyl and carboxyl groups in the polymer backbone. The inset of Figure 21 depicts
the enlarged version of the curve d, showing the redox currents observed with the
overoxidized PPy matrix.

Figure 21: CV scans of 5 mM K4[Fe(CN)6]/K3[Fe(CN)6] solution at (a) bare SPCE, (b) PPySPCE, (c) Cortisol-PPy-SPCE and (d) MIP-PPy-SPCE; scan rate of 50 mVs-1; (Inset:
Enlarged version of curve d).
5.5.3

Surface morphological characterization of cortisol MIP electrodes
Surface morphologies of MIP and NIP modified electrodes are obtained at the

magnification of x30,000x and are shown in Figure 22(A) shows the SEM image of
PPy coated SPCE. After electropolymerization, the surface of the SPCE is coated with
a microporous PPy matrix with cauliflower-like structure constituted by microspherical grains. The average diameter of the grain is 343.47 nm. When pyrrole was
polymerized in the presence of cortisol, an increase in grain size is noted (Figure
22C). The average diameter of the grains increased to 616.32 nm, suggesting the
incorporation of cortisol to the polymeric matrix. Overoxidation of PPy matrix
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leading to an increase in porosity and decrease in grain size due to the removal of
cortisol from the matrix (The average diameter of the grain size is 342.83 nm).

Figure 22: SEM images of (A) PPy-SPCE, (B) Cortisol-PPy-SPCE, (C) MIPPPy-SPCE, and (D) NIP-PPy-SPCE

For comparison, the SEM image of the NIP modified electrode is given in
Figure 22D. As can be seen from the SEM images, the surface of the MIP modified
electrode is rough due to cavities of cortisol whereas the surface of the NIP modified
electrode is smooth without the imprinting cavities. The distribution of polymer grain
size is given in Figure 23.
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Figure 23: Polymer grain size distributions observed for (A) PPy-SPCE, (B) Cortisol-PPySPCE, (C) MIP-PPy-SPCE, and (d) NIP-PPy-SPCE

5.5.4

Optimization of experimental parameters
The thickness of MIP film is an important factor affecting the film’s

recognition ability, reproducibility and it could be controlled by tuning the
concentration of monomer and a number of polymerization cycles.
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5.5.5

Effect of concentration of pyrrole monomer.

The effect of monomer concentrations on the electrochemical response of the MIP
sensor was investigated. The cortisol MIP electrodes were prepared in solutions of a

Figure 24: Effect of the monomer concentration on the response of the sensor to cortisol

Figure 25: Effect of the different cycles of the electro polymerization of MIP
constant concentration of cortisol (10 mM) and different pyrrole concentrations in the
range of 0.2 M to 1.2 M (Figure 24). The polymerization and elution of cortisol to
form MIP electrodes were followed as mentioned in the previous section. The
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fabricated MIP electrodes were then characterized using CV in 5 mM
K4[Fe(CN)6]/K3[Fe(CN)6] solution containing 0.1 M PBS. The current response of the
[Fe(CN)6]3-/[Fe(CN)6]4-

redox

probe

increased

with

increase

in

monomer

concentration and reached a maximum value at 0.8 M. The current response then
decreased with further increase in the concentration of pyrrole monomer. This
behavior can be attributed to the formation of a very thick layer of MIP at higher
concentration of monomer which in turn affects the electron transfer of [Fe(CN)6]3/[Fe(CN)6]4- redox couple. Thus, the optimized 0.8 M pyrrole monomer concentration
was chosen for the electrochemical polymerization to obtain the highest sensitivity for
the determination of cortisol.

Figure 26: Effect of electrochemical extraction cycle on the current response
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5.5.6

Effect of number of electropolymerization cycles and rate
Since the thickness of polymer matrix can also be tuned via controlling the

number of electro-polymerization cycles, the number of scan cycles used for MIP
synthesis was optimized. A series of MIP electrodes were fabricated by following the
experimental procedure mentioned in section 2.3 but with a different number of
polymerization cycles to find out the optimal number of polymerization cycle. The
electrochemical elution of cortisol template from the polymeric matrix was performed
using CV as detailed in section 3.1. As shown in Figure 25, the current response of
the redox probe [Fe(CN)6]3-/[Fe(CN)6]4- reached maximum after the tenth cycle of
polymerization, and then decreased with further increase in the number of
polymerization cycles. MIP films that were formed at less than 10 scan cycles were
found to be thin and less stable at the working electrode whereas higher than 10
cycles formed thicker sensing layer which hinders the electron transfer of [Fe(CN)6]3/[Fe(CN)6]4- redox probe. The current response changes of cortisol on MIP modified
electrode implied that the optimum polymerization cycle was to be 10.

Figure 27: concentration Curve after testing the Elute using ELISA
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5.5.7

Optimization of the extraction cycle

Figure 28: CV studies of the cortisol MIP sensor as a function of scan rate (50-150
mV/s), inset: magnitude of current response vs. scan rate.
Controlling and enhancing the formation of imprinting sites by regulating the
removal of target molecules from the polymeric matrix is essential to fabricate
reproducible MIP biosensors. An effective method is needed to regenerate the
imprinting sites after the binding event to make the MIP sensors reusable. In this
study, voltage induced target removal was performed to create imprinting sites. The
electrochemical elution of cortisol template from the polymeric matrix was performed
using CV as detailed in section 3.1. To optimize the extraction cycles, different
extraction cycles (5-40) were performed on the cortisol embedded PPy modified
SPCE. The MIP sensors were characterized after each cycle of target removal, using
the redox probe [Fe(CN)6]3-/[Fe(CN)6]4-. As the number of elution cycles increases,
the current response of the MIP sensor also increases indicating the controlled release
of cortisol molecule. The maximum current response of the electrode is obtained at
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the 25th cycle (Figure 26). Thus, the extraction cycles were optimized at 25 for
complete extraction of the template from the polymeric matrix.

5.5.8

Effect of binding time and scan rate

Figure 29: Effect of incubation time on current response of the cortisol MIP
The typical CV curves of the cortisol MIP sensor in [Fe(CN)6]3-/[Fe(CN)6]4redox probe at different scan rates ranging from 50 to 150 50 mV/s were studied and
are shown in Figure 28. As is observed in Figure 28, both the cathodic and anodic
peak currents were increased with an increase in scan rate from 50 to 150 mV/s. The
anodic and cathodic peak currents both are linearly proportional to the square root of
the appropriate scan rate, suggesting a diffusion-controlled behavior with an electron
transfer process [139].
The effect of the incubation time on the performance of the cortisol MIP
sensor was also investigated (Figure 29). After the extraction of cortisol, the MIP
sensors were left in contact with a standard solution of 10 pM cortisol for different
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incubation times (0-30 min). With increasing incubation time, the current responses of
the [Fe(CN)6]3-/[Fe(CN)6]4- redox probe decreases and then stabilize when the
incubation time is longer than 15 min. Thus, an incubation time of 15 min is adopted
in the subsequent work.

5.5.9

Effect of pH
To evaluate the influence of the pH on the performance of the cortisol MIP

sensor, the sensor was tested with a series of PBS with different pH, ranging from 5.8
to 7.8 (data not shown). The experimental results show that an increase in pH from
5.8 to 7.2 resulted in an increased peak current of [Fe(CN)6]3-/[Fe(CN)6]4- redox
probe; further increase in pH resulted in a decrease in peak current. The results
showed that the maximum current response occurred at pH 7.2. The optimum pH 7.2
was hence chosen for all the experiments.

5.5.10 Calibration curve of the sensor
The typical CV scans obtained for several concentrations of cortisol in 0.1 M
PBS containing five mM [Fe(CN)6]3-/[Fe(CN)6] 4- using the cortisol MIP sensor at 50
mV/s are shown in Error! Reference source not found.. The figure depicts the
magnitude of electrochemical current response which decreases as a function of
increasing cortisol concentration when incubated for 15 min. The decrease in current
response is attributed to the binding of cortisol molecules to the MIP sites that hinder
electron transport of [Fe(CN)6]3-/[Fe(CN)6]4- redox probe. A calibration curve
between the magnitude of the current response and logarithm of cortisol concentration
has been plotted (inset, Error! Reference source not found.). Cathodic peak current
observed at -0.35 V was used to plot calibration curves. The current responses to
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cortisol obtained with the MIP sensor were linear from 1 pM to 10 μM (r2=0.9925),
with a detection limit of 1 pM.

Figure 31: Electrochemical response studies of MIP-PPy-SPCE as a function of
cortisol concentration (1 pM to10 uM) using five mM K4[Fe(CN)6]/K3[Fe(CN)6]
solution, inset: calibration curve between the magnitude of response current and
logarithm of cortisol concentration

Figure 30: The change in peak current values observed at cortisol
MIP (blue) and NIP (red) electrode in the presence of cortisol and
other interferents individually each at 100 nM.
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Figure 32: Molecular structure of cortisol and its structural
analogs prednisolone, progesterone and lactate.

5.5.11 Selectivity, reproducibility, and repeatability

𝛽=

𝐼𝑝𝑎 (𝑀𝐼𝑃 𝑠𝑒𝑛𝑠𝑜𝑟)
𝐼𝑝𝑎 (𝑁𝐼𝑃 𝑠𝑒𝑛𝑠𝑜𝑟)

Equation: 3

One of the significant limitations of currently available commercial cortisol
immunoassay kits and immunosensors is their cross-reactivity and interference with
the cortisol structural analogs viz. progesterone and prednisolone [140, 141]. As
recently reviewed by Krasowski and his team, commercially available cortisol
immunoassay kits still have cross-reactivity more than 100% with the analogous
molecules, especially prednisolone [142]. So, there is a real need to develop an assay
for cortisol detection which has lower cross-reactivity with the analogous. Earlier,
Ramstorm and his group have evaluated the application of synthetic polymer capable
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of molecular recognition of cortisol with reduced cross-reactivity [136]. The MIP
prepared by this method showed only 36% cross-reactivity with the analog
prednisolone. In this work, selectivity assay for cortisol MIP sensor was carried out
using three interfering analytes, progesterone, prednisolone, and lactate. The change
in peak current values observed at MIP and NIP electrodes in the presence of cortisol
and other interferents individually each at 100 nM is shown in Figure 31.
The imprinting factor (β), a measure of the strength of interaction between the
target molecule and MIP sensor was calculated according to

𝛽=

𝐼𝑝𝑎 (𝑀𝐼𝑃 𝑠𝑒𝑛𝑠𝑜𝑟)
𝐼𝑝𝑎 (𝑁𝐼𝑃 𝑠𝑒𝑛𝑠𝑜𝑟)

Equation: 3

where Ipa is the cathodic peak current.
Table 3: Reproducibility experiments of the MIP-PPy-SPCE sensor
Cortisol
MIP 1
sensors
Current (µA)
30.11

2

3

4

5

RSD

29.61

28.24

30.39

28.59

4.16%

Table 4: Repeatability experiments of the cortisol MIP-PPy-SPCE sensor
Cortisol
solutions
Current (µA)

1

2

3

4

5

RSD

28.15

29.10

29.85

30.98

31.80

4.81%

The values of β were 10.25, 1.27, 1.41, and 1.33 for cortisol, lactate,
progesterone, and prednisolone respectively. From the values obtained, the MIP
sensor shows higher binding capability towards cortisol (maximum β value) over
other interferents. The above results revealed that the MIP sensor exhibited higher
recognition selectivity toward cortisol. The cross-reactivity percentage was also
calculated using the current values. It showed that lactate has very negligible
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interference (1.5%) while progesterone (11.4%) and prednisolone (18.3%) have
slightly higher cross-reactivity with cortisol detection. The chemical structures of
cortisol and other interferents are shown in Figure 32. As can be seen from the figure,
prednisolone and progesterone have chemical structures very similar to cortisol and
thus interfere with cortisol measurement. However, the percentage of cross-reactivity
of the present MIP sensors is much lower than the conventional immunoassay. Even
this small percentage of cross-reactivity of the cortisol MIP sensors will be addressed
in the future by computational modeling [143].
The controlled fabrication process provided good reproducibility for the MIP
sensors. Five sensors were prepared freshly and used to detect the same concentration
of cortisol (100 nM). These sensors were used to investigate their reproducibility.
Based on the current responses obtained, the relative standard deviation (RSD) was
calculated to be as 4.16%, confirming that the sensor had good reproducibility (Table
3). The RSD was determined by five successive measurements of a 100 nM cortisol
solution using the same cortisol MIP electrode (i.e., used each time after elution
process) and was estimated to be 4.81% (
Table 4). After the binding event, sensors were regenerated by electrochemical
elution and were reused to detect cortisol. The experimental results demonstrated that
the cortisol MIP sensor could be regenerated seven times; after that, the adhesion of
the polymer to the electrode is weakened. The stability of the sensor has been
examined by monitoring the current response for 10 nM cortisol solution at regular
intervals (2 days) for four weeks. After four weeks, the sensor retained 90% of the
current response. Suggesting, that the proposed sensor has acceptable stability.
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5.5.12 Analytical applications
To further investigate the feasibility of the newly developed cortisol MIP
sensor for clinical analysis, cortisol measurement in human saliva samples were
performed. The protocol to detect cortisol using the sensor and ELISA is adopted
from our previous work (Pasha et al., 2013). In brief, five µl of saliva samples were
placed on the biosensor and were allowed to incubate for 15 min to ensure proper
binding. The MIP sensors were then washed using 0.1 M PBS to remove unbound
saliva.

This

was

followed

by

the

recording

CV

scans

in

5

mM

K4[Fe(CN)6]/K3[Fe(CN)6] solution containing 0.1 M PBS. These results obtained
using the MIP cortisol sensor and estimation performed using ELISA are comparable
(Table 5). These results, therefore, confirm the suitability of the electrode for the real
sample applications.
Table 5: Comparison of saliva cortisol estimated using ELISA and cortisol
MIP sensor.
Saliva
samples

Salivary
Cortisol (MIP sensor)
(nM/L)
6.75

Sample

0.237

Sample

0.155

4.32

Sample

0.144

4.13

Sample

0.072

2.16

1
2
3
4

5.6

Salivary Cortisol (ELISA)
(µg/dL)

Conclusion
In summary, a novel electrochemical sensor for the determination of cortisol

was designed for the first time using molecular imprinting technique. The cortisol
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MIP sensor was created by electropolymerization of pyrrole monomer in the presence
of cortisol template, followed by removal of cortisol under optimized conditions. The
electrochemistry of [Fe(CN)6]3-/[Fe(CN)6]4- redox probe was used to characterize
stepwise fabrication of sensor and detection of cortisol. The sensor response was
linear to the cortisol concentration in the range 1 pM to 10 μM (r2=0.984), with a
detection limit of 1 pM. The sensor exhibited good sensitivity, short response time
and regenerated seven times. Also, the sensor showed good repeatability, stability,
and selectivity, and was applied to detect cortisol in real samples. Despite the
advantages of this approach, the use of electrochemical sensing requires complex
auxiliary electronics for detection. The output of the system is not a direct readout and
has to be correlated to the concentration of the curve by complex calculations. Apart
from that, the presence of electrolytic redox species as the label makes it difficult for
portable use.
The next chapter will discuss the application of MIP in an EGFET
configuration to address the above issues.
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INTEGRATION OF MIP WITH EGFET FOR DIRECT SENSING OF
CORTISOL

6.1

Abstract
Electrochemical immunosensing offers a fast and effective method for

detection of cortisol. However, it suffers from limitations such as difficulty in
implementing label-free sensing. One of the challenges for implementing
electrochemical immunosensing is the failure to provide a direct sensing readout for
the detected biomolecule. In this chapter, we will address the challenges faced by the
electrochemical method. The MIP sensor fabrication reported in the previous chapters
will be used in an EGFET configuration to provide label-free and repeatable sensing.
The proposed system is easy to implement and is cost effective. The most significant
advantage of using this method is the simplicity of the sensing system as it provides a
value of current that can be directly related to cortisol concentration. Another
advantage of the system is that it requires a simplistic approach to auxiliary
electronics. Thus, paving the way for miniaturized sensing devices.

6.2

Introduction
The first semiconductor device in the form of a transistor ushered in a

revolution for modern electronics. The days of vacuum tubes were gone, and powerhungry equipment made way for sleek and efficient devices. The development of
oxide semiconductor FET further allowed the rapid growth of semiconductor
electronics. The MOSFET has been one of the most critical devices for VLSI circuits.
This has enabled applications of electronics in control systems, data communication,
storage and processing at affordable costs.
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The effect of electric field on the conductivity of a conducting channel in a
semiconductor of the FET defines its current carrying capability (thus the name Field
Effect Transistor). MOSFETs, JFET, TFET, etc. are some of the types of FETs that
are available. However, despite individual differences, all FETs share a basic
underlying principle.
Two heavily doped n-type regions are created in a p-type substrate. These
regions serve as source and drain for the device. A thin layer of insulator (generally
silicon dioxide is deposited between the source and the drain. This insulating layer is
coated with a thin film of metal to serve as a gate contact pad. Metal contacts are
layered on top of the source and drain as well.
While in operation, the source is grounded, and a positive voltage applied
between the source gate (Vgs). The application of a Vgs causes an accumulation of
electrons between the source and drain regions. These accumulated electrons start to
form a conducting channel. Vgs determine the thickness of this channel. Now the
application of a drain voltage causes a current to flow between the drain and the
source. The magnitude of this current is dependent on the resistance of the channel
which in turn is dependent on the gate voltage.
The following equation can express the magnitude of drain current.
1
𝐼𝑑 = 𝛽(𝑉𝑔𝑠 − 𝑉𝑇 − 𝑉𝑑𝑠 )𝑉𝑑𝑠 𝐼𝑑
2

Equation 5

Where VT is known as the threshold voltage. The threshold voltage is the
value of Vgs beyond which the narrow conduction channel starts forming.
β is the trans-conductance parameter and expressed as
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𝛽 = 𝜇𝐶𝑜𝑥

𝑊
𝐿

Equation 6

β is a function of the mobility of the electrons (μ) in the inversion layer, the
gate insulator capacitance per area (Cox) and the channel width to length ratio (W/L).
A closer look at the trans-conductance parameter shows the linearity of the
FET device. As the Vds is increased, the current Id through the channel increases.
Effectively the FET behaves as a resistor whose resistance can be calculated by the
slope of the line from Vd vs. Id curves.
However, the channel width is uniform for small values of Vds. As Vds is
increased, the channel becomes narrower near the drain as compared to the source;
this results in the rolling of Id vs. Vd curve as shown in the figure below.
These properties of FET were first utilized by Bergveld et al.
electrophysiological applications resulting in a Configuration Called ISFET. With this
pioneering work, ISFET based sensors gained focus in the rapidly growing field of
biosensors and were utilized in several different ways. Fast response time, high
sensitivity, batch processing and the possibility of integrating on a single chip have
pushed FET sensors in the forefront of sensing technology.

6.3

EGFET
The EGFET is based on the principle of an ion sensitive FET. The ISFET

consists of a gate insulator, where the electrolyte can be immobilized. Instead of
having a direct metal contact on the gate, an external electrode dips in the electrolyte.

81

In the presence of a constant external gate voltage, a change in the
concentration of the ions present in the electrolyte can cause a potential change at the
surface of the gate insulator. The potential change, in turn, is responsible for the
modulation of the drain-source current in the FET. By using this configuration of
ISFET, biosensing applications are made possible. This is possible by immobilizing
bio sensitive moieties on the gate insulator surface. However, this configuration can
destroy the device due to often harsh chemical nature of the electrolytes used. The
EGFETS avoid this problem by isolating the chemical environment from the FET
itself. The system consists of an external functionalized substrate that is connecte4d to
the gate as shown in the figure below. The substrate has a well that limits the
electrolyte volume. The external electrode touches the electrolyte, and a gate voltage
is applied across it. The interaction between the ions present in the electrolyte and the
functional group present on the extended gate substrate causes a surface potential
change. This change of potential causes a change in the flow of current to the gate of
the FET. In turn, the gate current modulates the Drain-Source currents.
The Modulation of drain current due to the presence of biomolecules on the
surface of the extended gate makes it possible to use the FET as a biosensor. This
configuration also allows for the stabilization of FET by isolating it from changes
happening due to light and temperature variations as the gate material is not directly
exposed to the environment. In this research, we will be using EGFET configuration
along with molecularly imprinted polymers for the sensing of Cortisol.
This configuration will result in a system that provides a direct output as a
change in drain current due to variation in cortisol concentration. An SPCE was used
to fabricate MIP specific to cortisol. We report the fabrication and characterization of
MIP in detail in previous chapters.
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6.4

Materials and methods
The SPCE was a three-electrode system with an Ag/AgCL reference and two

Carbon electrodes. It was purchased from Zensor was used for the construction of
MIP biosensor. The thiol-based crosslinker, DTSP, and NaBH4 were purchased from
Thermo Fisher Scientific. Copper (II) Chloride (CuCl2), KCl and NaOH, used for
deposition of copper nanoparticles were obtained from Sigma Aldrich. The buffer
solution used for characterization was prepared from NaH2PO4 and Na2HPO4. These
chemicals were also purchased from Sigma Aldrich. All the chemicals were of
analytical grade and were used without further purification. The commercial
prepackaged FET IC (CD4007ube) was purchased from Texas Instruments.

6.5

Fabrication of EGFET sensor
Formation of MIP on the SPCE – the fabrication and characterization of the

MIP modified SPCE surface has been detailed in the previous chapter. The MIP
electrode was connected to the gate of the FET sensor as shown in Figure 33 below.
The gate of the FET was connected to the working electrode of the SPCE. The gate
voltage source was connected to the Reference electrode of the SPCE. The source and
drain were grounded and connected to the power source respectively. The output and
transfer characteristics of the FET (CD4007UB) were measured using the Keithley
4200 source meter. The output and transfer characteristics were measured by
connecting the gate directly to the Vg power supply and varying the gate voltage.
After establishing the baseline measurements of the transistor, measurements were
made with 50 µL of PBS with different pH values. Subsequent measurements were
made in PBS solution (7.6pH) after incubating different cortisol concentrations on the
MIP modified, extended gate.
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Figure 33: Scheme of the EGFET - MIP based sensing system

Figure 34: current response of the EGFET after the addition of PBS at different
pH Values.

6.6

Results and Discussions
The system was first tested without the extended gate to compare the output

and transfer characteristics as described in the Datasheet. The MIP modified,
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extended gate was then connected to the FET and output characteristics were repeated
with different pH solutions of PBS.

6.6.1

Study of pH response of the sensor
To evaluate the MIP EGFET sensor, it was tested with a series of PBS

solution with different pH values. The gate voltage was kept constant at 5V for this
study. The response of the system indicates that the current drops as the pH value
change from more neutral to a hydrogen-rich environment at pH 5.5, indicating the
formation of an ionic double layer. With lower pH values, the no of H+ ions in the
solution is higher. This causes a stronger charge interaction at the surface of the MIP.
This interaction results in a lower gate voltage. Thus, a lower drain current. The
highest response was obtained when PBS solution of pH 7.6 was used. This value is
closer to the pH of the biological system. Subsequent experiments were performed

Figure 35: Output characteristics of the EGFET after adding different cortisol
concentrations at a constant gate voltage of 5V
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using the same.

6.6.2

Drain current response of the sensor with respect to different cortisol

concentrations
Cortisol stock solution was prepared by dissolving Lyophilized Cortisol
powder in Ethanol and PBS solution of pH~7.4. The stock solution was then diluted
to obtain different cortisol concentrations. The MIP modified electrode was incubated
with 10 µL of cortisol for 30 minutes. It was then washed away with DI water and
dried with nitrogen. 50 µL of PBS was then dispensed on the electrode, and the I-V
measurements were made then. Figure 35 And Figure 36 shows the output
characteristics of different cortisol concentrations immobilized on the MIP modified,
extended gate. The Drain-source voltage was swept while the Gate voltage was kept

Figure 36: Different cortisol concentration at a lower gate voltage(1V). The reduction in
drain current with increasing cortisol can be hypothesized due to cortisol molecules
occupying empty sites in the MIP matrix and reducing electron transport in the polymer
matrix. The reduced gate current, causes a reduction in the accumulated charges at the actual
gate. Thus, causing a decrease in source drain current due to the reduced gate voltage.
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at 5 Volt and 1 Volt respectively.
Figure 35 And Figure 36, shows a decrease in drain current can be observed as
cortisol concentration increases. The cortisol molecules occupy the empty sites in the
polymer matrix. The occupation of conductive sites by cortisol causes a change in the
interaction of charge carrier with the polymer surface. The change in surface charges
restricts the flow of current across the MIP thin film. The reduced current, in effect,
decreases the electron density in the gate region of the n-type MOSFET working in
enhancement mode. This change in Drain current due to increased cortisol
concentration was used for sensing purpose [144].
Figure 37 shows the concentration curve for cortisol as plotted from the Vd vs.
Id data obtained in Figure 36. Drain current values at 2 Volts were chosen and plotted
against their respective concentration on a logarithmic scale.
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Figure 37: The concentration curve of the EGFET device from 1 pM to 100
nM cortisol concentration vs. the current measured at 2 Volts Vd and 1Volt Vgs

87

Figure 38: Vgs-Id curve of the EGFET-MIP device at different
cortisol concentrations. The drain voltage was kept as 1V

6.7

Conclusions
MIP based EGFET sensors were fabricated in this chapter. The MIP cortisol

sensor fabricated on SPCE in the previous chapter was used for this research. The
working electrode was connected to the gate of the FET and the Ag/AgCl reference
electrode was supplied with a gate voltage using an external power supply. The
EGFET could detect the changes in PBS solutions of Different Concentrations. It was
also able to detect the various concentration of Cortisol in PBS solution. The Limit of
detection of this sensor was found to be 1 pM. The fabricated sensor paves the way
for label-free, fast, low cost and direct sensing of cortisol. This work has potential
applications in POC sensing of cortisol.
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SUMMARY AND FUTURE WORK

7.1

Summary
The POC sensors are essential tools for providing healthcare and offer

accurate, timely, affordable and manageable diagnostics of targeted diseases. This
research aimed to explore different methodologies for sensing cortisol that would
enable fast, selective, sensitive, label-free and temperature stable sensors. Thin Filmbased electrochemical immunosensors were fabricated using self-assembled
monolayer functionalized by the anti-cortisol antibody. These sensors were validated
against Standard ELISA process using human saliva samples. The developed system
was fast, reliable and utilized electrochemical approach towards sense. However, it
suffered from some shortcomings. A redox label is required for making
electrochemical measurements. The sensors were sensitive to temperature variations,
and the system provided indirect output.
Further research in Nanomaterial modified electrode for label-free sensing was
conducted. Copper/Copper oxide nanoparticles were fabricated on SPCE. These nanomodified electrodes were used to fabricate immunosensors specific to cortisol. The
significant advantage of using this methodology was the avoidance of a Redox
medium for electrochemical measurements. The fabricated immunosensors had a
linear correlation from 100 µM to 100 pM (cortisol concentration) with a sensitivity
of 4.21 µA/M and the standard deviation of 0.0094. The estimated Limit of detection
was found to be 6.6 nM. However, the sensing system was still plagued with
temperature instability. The detecting moieties (antibodies and enzymes) were
sensitive to temperature changes and were denatured easily at higher than room
temperatures. A biomimetic sensor based on molecular imprinted polymer
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(polypyrrole) was explored at this for cortisol detection to mitigate this challenge. The
MIP based sensors were cheap to fabricate, temperature stable, gave label-free
detection and were reusable. The performance of the resulting sensors was
comparable to those of commercially available technologies (ELISA). The MIP
sensors were fabricated on SPCE and biosensing of cortisol was demonstrated using
CV. Though CV is a viable technique for POC biosensing, it does not provide a direct
readout. A much simpler system is reported where MIP is along with a FET in an
extended gate configuration. This system was easy to construct, can be ported to
miniaturized electronics and can provide a direct readout. In this last study, cortisol of
different concentration was detected in a label-free setting to pave the way for truly
miniaturized reusable, cheap, fast and accurate biosensing system for POC. The
performance of all the sensors fabricated in this study is summarised in Table 6
below. The MIP-EGFET sensor meets all the criteria in the table that makes it the best
candidate to explore POC/wearable sensors for detection of Cortisol.
Table 6: Comparison of Cortisol sensors fabricated during this research
SAM
based Cu/CuO
Electrochemical Nanomodified
immunosensor
Electrochemical
immunosensor
Sensing
element

MIP
based MIPElectrochemical EGFET
Sensor
sensor

Cortisol specific Cortisol specific MIP
Monoclonal
Monoclonal
Antibodies
Antibodies

MIP

Mode
of CV
detection

CV

CV

EGFET

Label free

No

Yes

Yes

Yes

Reusable

No

No

Yes

Yes

Direct
readout

No

No

No

Yes

Yes

Yes

Yes

Selective to Yes
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Cortisol
Limit
of 10 pg/mL
detection
for cortisol

7.2

0.002 pg/mL

0.0004 pg/mL

0.0004
pg/mL

Future work
This research has validated techniques and methods which has potential

application for POC sensing of cortisol (a vital Steroid Biomarker for detection of
stress). This work focused on addressing critical issues that face sensing systems for
POC application. There are still challenges that require addressing before a
commercially viable system is available. The molecularly Imprinted Technique is a
promising technique for biosensing application. However, there is much room for
improvement regarding having an extremely selective polymer.
The selectivity of the MIP can be improved by computationally exploring the
interaction between the polymer and the bioanalyte.
The Simulation studies of different binding sites at the polymer can be useful
for better understanding of loading/elution mechanism of the target molecule.
Computationally exploring the energy required for effective removal of the target
molecule without affecting the molecular backbone etc.
At the device end, the EGFET configuration is promising. It can be
incorporated with miniaturized electronics to provide a direct readout in handheld or
wearable device form and integrated with MIP based sensing electrodes.
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